Lycopene, Tomatoes, Tomato-Based Food Products and the Prevention of Cancer

References Cited for: Lycopene, Tomatoes, Tomato-Based Food Products and the Prevention of Cancer

1. Khachik F, Carvalho L, Bernstein PS, Muir GJ, Zhao DY, Katz NB. Chemistry, distribution, and metabolism of tomato carotenoids and their impact on human health. Exp Biol Med 2002;227:845-851.
2. Boileau TW-M, Boileau AC, John W. Erdman JW Jr. Bioavailability of all-trans and cis-isomers of lycopene. Exptl Biol Med 2002;227:914-919.
3. Olson JA. The conversion of radioactive ?-carotene into vitamin A by rat small intestine in vivo. J Biol Chem 1961;236:349-356.
4. Olson JA. Provitamin A function of carotenoids: The conversion of ?-carotene into vitamin A. J Nutr 1989;119:105-108.
5. United States Department of Agriculture. USDA Tables of the Nutrient Composition of Foods, Release 16. United States Department of Agriculture, Washington, DC, 2003.
6. Tonucci LH, Holden JM, Beecher GR, Khachik F, Davis CS, Mulokozi G. Carotenoid content of thermally processed tomato-based food products. J Agric Food Chem 1995;43:579-586.
7. Clinton SK, Emenhiser C, Schwartz SJ, Bostwick DG, Williams AW, Moore BJ, Erdman JW Jr. cis-trans lycopene isomers, carotenoids and retinol in the human prostate. Cancer Epidemiol Biomarkers Prev 1996;5:823-833.
8. Gartner C, Stahl W, Sies H. Lycopene is more bioavailable from tomato paste than from fresh tomatoes. Am J Clin Nutr 1997;66:116-122.
9. Nguyen ML, Schwartz SJ. Lycopene stability during food processing. Proc Soc Exp Biol Med 1998;218:101-105.
10. Schierle J, Bretzel W, Buhler I, Faccin N, Hess D, Steiner K, Schuep W. Content and isomeric ratios of lycopene in food and human blood plasma. Food Chem 1997;59:459-465.
11. Shi J, Le Maguer M. Lycopene in tomatoes: Chemical and physical properties affected by food processing. Crit Rev Biotechnol 2000;20:293-334.
12. Agarwal A, Shen H, Agarwal S, Rao AV. Lycopene content of tomato products: Its stability, bioavailability and in vivo antioxidant properties. J Med Food 2001;4:9-15.
13. Khachik F, Goli MB, Beecher GR, Holden J, Lusby WR, Tenorio MD, Barrera MR. The effect of food preparation on qualitative and quantitative distribution of major carotenoid constituents of tomatoes and several green vegetables. J Agric Food Chem 1992;40:390-398.
14. United States Department of Agriculture. USDA Table of Nutrient Retention Factor, Release 5. United States Department of Agriculture, Washington, DC, 2003.
15. Clinton SK. Lycopene: Chemistry, biology, and implications for human health and disease. Nutr Rev 1998;56:35-51.
16. Williams AW, Boileau TWM, Erdman JW Jr. Factors influencing the uptake and absorption of carotenoids. Proc Exp Biol Med 1998;218:106-108.
17. van het Hof KH, de Boer BC, Tijburg LB, Lucius BR, Zijp I, West CE, Hautvast JG, Weststrate JA. Carotenoid bioavailability in humans from tomatoes processed in different ways determined from the carotenoid response in the triglyceride-rich lipoprotein fraction of plasma after a single consumption and in plasma after four days of consumption. J Nutr 2000;130:1189-1196.
18. Re R, Fraser PD, Long M, Brameley PM, Rice-Evans C. Isomerization of lycopene in the gastric milieu. Biochem Biophys Res Commun 2001;281:576-581.
19. Boileau AC, Merchen NR, Wasson K, Atkinson CA, Erdman JW Jr. Cis-lycopene is more bioavailable than trans lycopene in vitro and also in vivo in the lymph cannulated ferret. J Nutr 1999;129:1176-1181.
20. Porrini M, Riso P, Testolin G. Absorption of lycopene from single or daily portions of raw and processed tomato. Br J Nutr 1998;80:353-361.
21. Stahl W, Sies H. Uptake of lycopene and its geometrical isomers is greater from heat-processed than from unprocessed tomato juice in humans. J Nutr 1992;122:2161-2166.
22. Holloway DE, Yang M, Paganga G, Rice-Evans CA, Bramley PM. Isomerization of dietary lycopene during assimilation and transport in plasma. Free Radic Res 2000;32:93-102.
23. Cohn W, Schalch W, Thurmann P, Aebischer C, Schierle J, Elliott J. Lycopene concentrations in plasma after consumption of tablets containing lycopene in beadlets or lycopene from natural sources (abstract). Proceedings, International Symposium on the Role of Tomato Products and Carotenoids in Disease Prevention, New York City, April 10, 2001, poster 12, unpaged.
24. Bohm V, Bitsch R. Intestinal absorption of lycopene from different matrices and interactions to other carotenoids, the lipid status, and the antioxidant capacity of human plasma. Eur J Nutr 1999;38:118-125.
25. Norrish AE, Jackson RT, Sharpe SJ, Skeaff CM. Men who consume vegetable oils rich in monounsaturated fat: their dietary patterns and risk of prostate cancer (New Zealand). Cancer Causes Control 2000;11:609-615.
26. Djuric Z, Uhley VE, Naegeli L, Lababidi S, Macha S, Heilbrun LK. Plasma carotenoids, tocopherols, and antioxidant capacity in a 12-week intervention study to reduce fat and/or energy intakes. Nutrition 2003;19:244-249.
27. Velthuis-te Wierik EJM, van den Berg H, Weststrate JA, van het Hof KH, de Graaf C. Consumption of reduced-fat products: effects on parameters of anti-oxidative capacity. Eur J Clin Nutr 1996;50:214-219.
28. Clark RM, Yao L, She L, Furr HC. A comparison of lycopene and astaxanthin absorption from corn oil and olive oil emulsions. Lipids 2000;35:803-806.
29. Diwadkar-Navsariwala V, Novotny JA, Gustin DM, Sosman JA, Rodvold KA, Crowell JA, Stacewicz-Sapuntzakis M, Bowen PE. A physiological pharmacokinetic model describing the disposition of lycopene in healthy men. J Lipid Res 2003, published in electronic form July 16, 2002, as manuscript M300130-JLR200.
30. Garrett DA, Failla ML, Sarama RJ. Estimation of carotenoid bioavailability from fresh stir-fried vegetables using an in vitro digestion/Caco-2 cell culture model. J Nutr Biochem 2000;11:574-580.
31. Tyssandier V, Reboul E, Dumas JF, Bouteloup-Demange C, Armand M, Marcand J, Sallas M, Borel P. Processing of vegetable-borne carotenoids in the human stomach and duodenum. Am J Physiol Gastrointest Liver Physiol 2003;284:G913-G923.
32. O'Neill ME, Thurnham DI. Intestinal absorption of beta-carotene, lycopene and lutein in men and women following a standard meal: Response curves in the triacylglycerol-rich lipoprotein fraction. Br J Nutr 1998;79:149-159.
33. Musaeus N, Nowakowsky B, Kramer K. A new stabilized form of lycopene (abstract). Contributions to the 13th International Carotenoid Society Symposium, Honolulu, January 6 - 11, 2002, unpaged.
34. Hoppe PP, Kramer K, van den Berg H, Steenge G, van Vliet T. Synthetic and tomato-based lycopene have identical bioavailability in humans (abstract). Contributions to the 13th International Carotenoid Society Symposium, Honolulu, January 6 - 11, 2002, unpaged.
35. Record IR, Dreosti IE, McInerney JK. Changes in plasma antioxidant status following consumption of diets high or low in fruit and vegetables or following dietary supplementation with an antioxidant mixture. Br J Nutr 2001;85:459-464.
36. Ahuja KD, Ashton EL, Ball MJ. Effects of a high monounsaturated fat, tomato-rich diet on serum levels of lycopene. Eur J Clin Nutr 2003;57:832-841.
37. Albanes D, Virtamo J, Taylor PR, Rautalahti M, Pietinen P, Heinonen OP. Effects of supplemental beta-carotene, cigarette smoking, and alcohol consumption on serum carotenoids in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study. Am J Clin Nutr 1997;66:366-372.
38. Allen CM, Smith AM, Clinton SK, Schwartz SJ. Tomato consumption increases lycopene isomer concentrations in breast milk and plasma of lactating women. J Am Diet Assoc 2002;102:1257-1262.
39. Breslow RA, Alberg AJ, Helzlsouer KJ, Bush TL, Norkus EP, Morris JS, Spate VE, Comstock GW. Serological precursors of cancer: malignant melanoma, basal and squamous cell skin cancer, and prediagnostic levels of retinol, beta-carotene, lycopene, alpha-tocopherol, and selenium. Cancer Epidemiol Biomarkers Prev 1995;4:837-842.
40. Brown ED, Micozzi MS, Craft NE, Bieri JG, Beecher G, Edwards BK, Rose A, Taylor PR, Smith JC Jr. Plasma carotenoids in normal men after a single ingestion of vegetables or purified beta-carotene. Am J Clin Nutr 1989;49:1258-1265.
41. Buiatti E, Munoz N, Kato I, Vivas J, Muggli R, Plummer M, Benz M, Franceschi S, Oliver W. Determinants of plasma anti-oxidant vitamin levels in a population at high risk for stomach cancer. Int J Cancer 1996;65:317-322.
42. Caperle M, Maiani G, Azzini E, Conti EM, Raguzzini A, Ramazzotti V, Crespi M. Dietary profiles and anti-oxidants in a rural population of central Italy with a low frequency of cancer. Eur J Cancer Prev 1996;5:197-206.
43. Casso D, White E, Patterson RE, Agurs-Collins T, Kooperberg C, Haines PS. Correlates of serum lycopene in older women. Nutr Cancer 2000;36:163-169.
44. Chen L, Stacewicz-Sapuntzakis M, Duncan C, Sharifi R, Ghosh L, van Breemen R, Ashton D, Bowen PE. Oxidative DNA damage in prostate cancer patients consuming tomato sauce-based entrees as a whole-food intervention. J Natl Cancer Inst 2001;93:1872-1879.
45. Comstock GW, Alberg AJ, Huang HY, Wu K, Burke AE, Hoffman SC, Norkus EP, Gross M, Cutler RG, Morris JS, Spate VL, Helzlsouer KJ. The risk of developing lung cancer associated with antioxidants in the blood: Ascorbic acid, carotenoids, alpha-tocopherol, selenium, and total peroxyl radical absorbing capacity. Cancer Epidemiol Biomarkers Prev 1997;6:907-916.
46. Dietrich M, Block G, Norkus EP, Hudes M, Traber MG, Cross CE, Packer L. Smoking and exposure to environmental tobacco smoke decrease some plasma antioxidants and increase gamma-tocopherol in vivo after adjustment for dietary antioxidant intakes. Am J Clin Nutr 2003;77:160-166.
47. Edwards AJ, Vinyard BT, Wiley ER, Brown ED, Collins JK, Perkins-Veazie P, Baker RA, Clevidence BA. Consumption of watermelon juice increases plasma concentrations of lycopene and beta-carotene in humans. J Nutr 2003;133:1043-1050.
48. Giuliano AR, Papenfuss M, Nour M, Canfield LM, Schneider A, Hatch K. Antioxidant nutrients: associations with persistent human papillomavirus infection. Cancer Epidemiol Biomarkers Prev 1997;6:917-923.
49. Gomez-Aracena J, Bogers R, Van't Veer P, Gomez-Gracia E, Garcia-Rodriguez A, Wedel H, Fernandez-Crehuet Navajas J. Vegetable consumption and carotenoids in plasma and adipose tissue in Malaga, Spain. Int J Vitam Nutr Res 2003;73:24-31.
50. Goodman MT, Kiviat N, McDuffie K, Hankin JH, Hernandez B, Wilkens LR, Franke A, Kuypers J, Kolonel LN, Nakamura J, Ing G, Branch B, Bertram CC, Kamemoto L, Sharma S, Killeen J. The association of plasma micronutrients with the risk of cervical dysplasia in Hawaii. Cancer Epidemiol Biomarkers Prev 1998;7:537-544.
51. Hadley CW, Clinton SK, Schwartz SJ. The consumption of processed tomato products enhances plasma lycopene concentrations in association with a reduced lipoprotein sensitivity to oxidative damage. J Nutr 2003;133:727-732.
52. Helzlsouer KJ, Alberg AJ, Norkus EP, Morris JS, Hoffman SC, Comstock GW. Prospective study of serum micronutrients and ovarian cancer. J Natl Cancer Inst 1996;88:32-37.
53. Helzlsouer KJ, Comstock GW, Morris JS. Selenium, lycopene, alpha-tocopherol, beta-carotene, retinol, and subsequent bladder cancer. Cancer Res 1989;49:6144-6148.
54. Huang HY, Alberg AJ, Norkus EP, Hoffman SC, Comstock GW, Helzlsouer KJ. Prospective study of antioxidant micronutrients in the blood and the risk of developing prostate cancer. Am J Epidemiol 2003;157:335-344.
55. Hulten K, Van Kappel AL, Winkvist A, Kaaks R, Hallmans G, Lenner P, Riboli E. Carotenoids, alpha-tocopherols, and retinol in plasma and breast cancer risk in northern Sweden. Cancer Causes Control 2001;12:529-357.
56. Ito Y, Gajalakshmi KC, Sasaki R, Suzuki K, Shanta V. A study on serum carotenoid levels in breast cancer patients of Indian women in Chennai (Madras), India. J Epidemiol 1999;9:306-314.
57. Ito Y, Suzuki K, Suzuki S, Sasaki R, Otani M, Aoki K. Serum antioxidants and subsequent mortality rates of all causes or cancer among rural Japanese inhabitants. Int J Vitam Nutr Res 2002;72:237-250.
58. Ito Y, Suzuki S, Yagyu K, Sasaki R, Suzuki K, Aoki K. Relationship between serum carotenoid levels and cancer death rates in the residents, living in a rural area of Hokkaido, Japan. J Epidemiol 1997;7:1-8.
59. Ito Y, Wakai K, Suzuki K, Tamakoshi A, Seki N, Ando M, Nishino Y, Kondo T, Watanabe Y, Ozasa K, Ohno Y; JACC Study Group. Serum carotenoids and mortality from lung cancer: A case-control study nested in the Japan Collaborative Cohort (JACC) study. Cancer Sci 2003;94:57-63.
60. John JH, Ziebland S, Yudkin P, Roe LS, Neil HA; Oxford Fruit and Vegetable Study Group. Effects of fruit and vegetable consumption on plasma antioxidant concentrations and blood pressure: A randomised controlled trial. Lancet 2002;359:1969-1974.
61. Kanetsky PA, Gammon MD, Mandelblatt J, Zhang ZF, Ramsey E, Dnistrian A, Norkus EP, Wright TC Jr. Dietary intake and blood levels of lycopene: Association with cervical dysplasia among non-Hispanic, black women. Nutr Cancer 1998;31:31-40.
62. Kucuk O, Sarkar FH, Sakr W, Djuric Z, Pollak MN, Khachik F, Li YW, Banerjee M, Grignon D, Bertram JS, Crissman JD, Pontes EJ, Wood DP Jr. Phase II randomized clinical trial of lycopene supplementation before radical prostatectomy. Cancer Epidemiol Biomarkers Prev 2001;10:861-868.
63. Le Marchand L, Hankin JH, Carter FS, Essling C, Luffey D, Franke AA, Wilkens LR, Cooney RV, Kolonel LN. A pilot study on the use of plasma carotenoids and ascorbic acid as markers of compliance to a high fruit and vegetable dietary intervention. Cancer Epidemiol Biomarkers Prev 1994;3:245-251.
64. Lu QY, Hung JC, Heber D, Go VL, Reuter VE, Cordon-Cardo C, Scher HI, Marshall JR, Zhang ZF. Inverse associations between plasma lycopene and other carotenoids and prostate cancer. Cancer Epidemiol Biomarkers Prev 2001;10:749-756.
65. Mayne ST, Cartmel B, Silva F, Kim CS, Fallon BG, Briskin K, Zheng T, Baum M, Shor-Posner G, Goodwin WJ Jr. Plasma lycopene concentrations in humans are determined by lycopene intake, plasma cholesterol concentrations and selected demographic factors. J Nutr 1999;129:849-854.
66. McEligot AJ, Rock CL, Flatt SW, Newman V, Faerber S, Pierce JP. Plasma carotenoids are biomarkers of long-term high vegetable intake in women with breast cancer. J Nutr 1999;129:2258-2263.
67. McMillan DC, Talwar D, Sattar N, Underwood M, O'Reilly DS, McArdle C. The relationship between reduced vitamin antioxidant concentrations and the systemic inflammatory response in patients with common solid tumours. Clin Nutr 2002;21:161-164.
68. Michaud DS, Giovannucci EL, Ascherio A, Rimm EB, Forman MR, Sampson L, Willett WC. Associations of plasma carotenoid concentrations and dietary intake of specific carotenoids in samples of two prospective cohort studies using a new carotenoid database. Cancer Epidemiol Biomarkers Prev 1998;7:283-290.
69. Micozzi MS, Brown ED, Edwards BK, Bieri JG, Taylor PR, Khachik F, Beecher GR, Smith JC Jr. Plasma carotenoid response to chronic intake of selected foods and beta-carotene supplements in men. Am J Clin Nutr 1992;55:1120-1125.
70. Muller H, Bub A, Watzl B, Rechkemmer G. Plasma concentrations of carotenoids in healthy volunteers after intervention with carotenoid-rich foods. Eur J Nutr 1999;38:35-44.
71. Nagao T, Ikeda N, Warnakulasuriya S, Fukano H, Yuasa H, Yano M, Miyazaki H, Ito Y. Serum antioxidant micronutrients and the risk of oral leukoplakia among Japanese. Oral Oncol 2000;36:466-470.
72. Nagata C, Shimizu H, Yoshikawa H, Noda K, Nozawa S, Yajima A, Sekiya S, Sugimori H, Hirai Y, Kanazawa K, Sugase M, Kawana T. Serum carotenoids and vitamins and risk of cervical dysplasia from a case-control study in Japan. Br J Cancer 1999;81:1234-1237.
73. Nair S, Norkus EP, Hertan H, Pitchumoni CS. Serum and colon mucosa micronutrient antioxidants: Differences between adenomatous polyp patients and controls. Am J Gastroenterol 2001;96:3400-3405.
74. Nierenberg DW, Dain BJ, Mott LA, Baron JA, Greenberg ER. Effects of 4 y of oral supplementation with beta-carotene on serum concentrations of retinol, tocopherol, and five carotenoids. Am J Clin Nutr 1997;66:315-319.
75. Nomura AM, Stemmermann GN, Lee J, Craft NE. Serum micronutrients and prostate cancer in Japanese Americans in Hawaii. Cancer Epidemiol Biomarkers Prev 1997;6:487-491.
76. Nomura AM, Ziegler RG, Stemmermann GN, Chyou PH, Craft NE. Serum micronutrients and upper aerodigestive tract cancer. Cancer Epidemiol Biomarkers Prev 1997;6:407-412.
77. Olmedilla B, Granado F, Southon S, Wright AJ, Blanco I, Gil-Martinez E, van den Berg H, Thurnham D, Corridan B, Chopra M, Hininger I. A European multicentre, placebo-controlled supplementation study with alpha-tocopherol, carotene-rich palm oil, lutein or lycopene: Analysis of serum responses. Clin Sci 2002;102:447-456.
78. Paetau I, Khachik F, Brown ED, Beecher GR, Kramer TR, Chittams J, Clevidence BA. Chronic ingestion of lycopene-rich tomato juice or lycopene supplements significantly increases plasma concentrations of lycopene and related tomato carotenoids in humans. Am J Clin Nutr 1998;68:1187-1195.
79. Paetau I, Rao D, Wiley ER, Brown ED, Clevidence BA. Carotenoids in human buccal mucosa cells after 4 wk of supplementation with tomato juice or lycopene supplements. Am J Clin Nutr 1999;70:490-494.
80. Palan PR, Chang CJ, Mikhail MS, Ho GY, Basu J, Romney SL. Plasma concentrations of micronutrients during a nine-month clinical trial of beta-carotene in women with precursor cervical cancer lesions. Nutr Cancer 1998;30:46-52.
81. Palan PR, Mikhail MS, Goldberg GL, Basu J, Runowicz CD, Romney SL. Plasma levels of beta-carotene, lycopene, canthaxanthin, retinol, and alpha- and tau-tocopherol in cervical intraepithelial neoplasia and cancer. Clin Cancer Res 1996;2:181-185.
82. Pappalardo G, Maiani G, Mobarhan S, Guadalaxara A, Azzini E, Raguzzini A, Salucci M, Serafini M, Trifero M, Illomei G, Ferro-Luzzi A. Plasma (carotenoids, retinol, alpha-tocopherol) and tissue (carotenoids) levels after supplementation with beta-carotene in subjects with precancerous and cancerous lesions of sigmoid colon. Eur J Clin Nutr 1997;51:661-666.
83. Peng Y-M, Peng Y-S, Childers JM, Hatch KD, Roe DJ, Lin Y, Lin P. Concentrations of carotenoids, tocopherols, and retinol in paired plasma and cervical tissue of patients with cervical cancer, precancer, and noncancerous diseases. Cancer Epidemiol Biomarkers Prev 1998;7:347-350.
84. Peng Y-M, Peng Y-S, Lin Y, Moon T, Baier M. Micronutrient concentrations in paired skin and plasma of patients with actinic keratoses: Effect of prolonged retinol supplementation. Cancer Epidemiol Biomarkers Prev 1993;2:145-150.
85. Porrini M, Riso P. Lymphocyte lycopene concentration and DNA protection from oxidative damage is increased in women after a short period of tomato consumption. J Nutr 2000;130:189-192.
86. Potischman N, Byers T, Houghton L, Root M, Nemoto T, Campbell TC. Effects of breast cancer treatments on plasma nutrient levels: Implications for epidemiological studies. Cancer Epidemiol Biomarkers Prev 1992;1:555-559.
87. Potischman N, Herrero R, Brinton LA, Reeves WC, Stacewicz-Sapuntzakis M, Jones CJ, Brenes MM, Tenorio F, de Britton RC, Gaitan E. A case-control study of nutrient status and invasive cervical cancer. II. Serologic indicators. Am J Epidemiol 1991;134:1347-1355.
88. Potischman N, Hoover RN, Brinton LA, Swanson CA, Herrero R, Tenorio F, de Britton RC, Gaitan E, Reeves WC. The relations between cervical cancer and serological markers of nutritional status. Nutr Cancer 1994;21:193-201.
89. Rao AV, Agarwal S. Bioavailability and in vivo antioxidant properties of lycopene from tomato products and their possible role in the prevention of cancer. Nutr Cancer 1998;31:199-203.
90. Rao AV, Fleshner N, Agarwal S. Serum and tissue lycopene and biomarkers of oxidation in prostate cancer patients: A case-control study. Nutr Cancer 1999;33:159-164.
91. Richelle M, Bortlik K, Liardet S, Hager C, Lambelet P, Baur M, Applegate LA, Offord EA. A food-based formulation provides lycopene with the same bioavailability to humans as that from tomato paste. J Nutr 2002;132:404-408.
92. Rock CL, Flatt SW, Wright FA, Faerber S, Newman V, Kealey S, Pierce JP. Responsiveness of carotenoids to a high vegetable diet intervention designed to prevent breast cancer recurrence. Cancer Epidemiol Biomarkers Prev 1997;6:617-623.
93. Sasaki S, Tsubono Y, Okubo S, Hayashi M, Kakizoe T, Tsugane S. Effects of three-month oral supplementation of beta-carotene and vitamin C on serum concentrations of carotenoids and vitamins in middle-aged subjects: A pilot study for a randomized controlled trial to prevent gastric cancer in high-risk Japanese population. Jpn J Cancer Res 2000;91:464-470.
94. Sato R, Helzlsouer KJ, Alberg AJ, Hoffman SC, Norkus EP, Comstock GW. Prospective study of carotenoids, tocopherols, and retinoid concentrations and the risk of breast cancer. Cancer Epidemiol Biomarkers Prev 2002;11:451-457.
95. Schiff MA, Patterson RE, Baumgartner RN, Masuk M, van Asselt-King L, Wheeler CM, Becker TM. Serum carotenoids and risk of cervical intraepithelial neoplasia in Southwestern American Indian women. Cancer Epidemiol Biomarkers Prev 2001;10:1219-1222.
96. Sedjo RL, Roe DJ, Abrahamsen M, Harris RB, Craft N, Baldwin S, Giuliano AR. Vitamin A, carotenoids, and risk of persistent oncogenic human papillomavirus infection. Cancer Epidemiol Biomarkers Prev 2002;11:876-884.
97. Simon MS, Djuric Z, Dunn B, Stephens D, Lababidi S, Heilbrun LK. An evaluation of plasma antioxidant levels and the risk of breast cancer: A pilot case control study. Breast J 2000;6:388-395.
98. Smith-Warner SA, Elmer PJ, Tharp TM, Fosdick L, Randall B, Gross M, Wood J, Potter JD. Increasing vegetable and fruit intake: Randomized intervention and monitoring in an at-risk population. Cancer Epidemiol Biomarkers Prev 2000;9:307-317.
99. Stryker WS, Stampfer MJ, Stein EA, Kaplan L, Louis TA, Sober A, Willett WC. Diet, plasma levels of beta-carotene and alpha-tocopherol, and risk of malignant melanoma. Am J Epidemiol 1990;131:597-611.
100. Sutherland WH, Walker RJ, De Jong SA, Upritchard JE. Supplementation with tomato juice increases plasma lycopene but does not alter susceptibility to oxidation of low-density lipoproteins from renal transplant recipients. Clin Nephrol 1999;52:30-36.
101. Toniolo P, Van Kappel AL, Akhmedkhanov A, Ferrari P, Kato I, Shore RE, Riboli E. Serum carotenoids and breast cancer. Am J Epidemiol 2001;153:1142-1147.
102. Trichopoulou A, Benetou V, Lagiou P, Gnardellis Ch, Stacewicz-Sapunzakis M, Papas A. Plasma carotenoid levels in relation to the Mediterranean diet in Greece. Int J Vitam Nutr Res 2003;73:221-225.
103. Tsubono Y, Tsugane S, Gey KF. Plasma antioxidant vitamins and carotenoids in five Japanese populations with varied mortality from gastric cancer. Nutr Cancer 1999;34:56-61.
104. Tsugane S, Tsuda M, Gey F, Watanabe S. Cross-sectional study with multiple measurements of biological markers for assessing stomach cancer risks at the population level. Environ Health Perspect 1992;98:207-210.
105. van Breemen RB, Xu X, Viana MA, Chen L, Stacewicz-Sapuntzakis M, Duncan C, Bowen PE, Sharifi R. Liquid chromatography-mass spectrometry of cis- and all-trans-lycopene in human serum and prostate tissue after dietary supplementation with tomato sauce. J Agric Food Chem 2002;50:2214-2219.
106. VanEenwyk J, Davis FG, Bowen PE. Dietary and serum carotenoids and cervical intraepithelial neoplasia. Int J Cancer 1991;48:34-38.
107. Vogt TM, Mayne ST, Graubard BI, Swanson CA, Sowell AL, Schoenberg JB, Swanson GM, Greenberg RS, Hoover RN, Hayes RB, Ziegler RG. Serum lycopene, other serum carotenoids, and risk of prostate cancer in US Blacks and Whites. Am J Epidemiol 2002;155:1023-1032.
108. Wahlqvist ML, Wattanapenpaiboon N, Macrae FA, Lambert JR, MacLennan R, Hsu-Hage BH. Changes in serum carotenoids in subjects with colorectal adenomas after 24 mo of beta-carotene supplementation. Australian Polyp Prevention Project Investigators. Am J Clin Nutr 1994;60:936-943.
109. Watzl B, Bub A, Blockhaus M, Herbert BM, Luhrmann PM, Neuhauser-Berthold M, Rechkemmer G. Prolonged tomato juice consumption has no effect on cell-mediated immunity of well-nourished elderly men and women. J Nutr 2000;130:1719-1723.
110. Watzl B, Bub A, Brandstetter BR, Rechkemmer G. Modulation of human T-lymphocyte functions by the consumption of carotenoid-rich vegetables. Br J Nutr 1999;82:383-389.
111. Wu K, Schwartz SJ, Platz EA, Clinton SK, Erdman JW Jr, Ferruzzi MG, Willett WC, Giovannucci EL. Variations in plasma lycopene and specific isomers over time in a cohort of U.S. men. J Nutr 2003;133:1930-1936.
112. Yeum K-J, Ahn SH, Rupp de Paiva SA, Lee-Kim YC, Krinsky NI, Russell RM. Correlation between carotenoid concentrations in serum and normal breast adipose tissue of women with benign breast tumor or breast cancer. J Nutr 1998;128:1920-1926.
113. Yu M-W, Chiu Y-H, Chiang Y-C, Chen C-H, Lee T-H, Santella RM, Chern H-D, Liaw Y-F, Chen C-J. Plasma carotenoids, glutathione S-transferase M1 and T1 genetic polymorphisms, and risk of hepatocellular carcinoma: independent and interactive effects. Am J Epidemiol 1999;149:621-629.
114. Gann PH, Ma J, Giovannucci E, Willett W, Sacks FM, Hennekens CH, Stampfer MJ. Lower prostate cancer risk in men with elevated plasma lycopene levels: Results of a prospective analysis. Cancer Res 1999;59:1225-1230.
115. Bowen P, Chen L, Stacewicz-Sapuntzakis M, Duncan C, Sharifi R, Ghosh L, Kim HS, Christov-Tzelkov K, van Breemen R. Tomato sauce supplementation and prostate cancer: Lycopene accumulation and modulation of biomarkers of carcinogenesis. Exp Biol Med 2002;227:886-893.
116. Burney PGJ, Comstock GW, Morris JS. Serologic precursors of cancer: Serum micronutrients and the subsequent risk of pancreatic cancer. Am J Clin Nutr 1989;49:895-900.
117. Dorgan JF, Sowell A, Swanson CA, Potischman N, Miller R, Schussler N, Stephenson HE Jr. Relationships of serum carotenoids, retinol, ?-tocopherol, and selenium with breast cancer risk: Results from a prospective study in Columbia, Missouri (United States). Cancer Causes Control 1998;9:89-97.
118. London SJ, Stein EA, Henderson IC, Stampfer MJ, Wood WC, Remine S, Dmochowski JR, Robert NJ, Willett WC. Carotenoids, retinol, and vitamin E and risk of proliferative benign breast disease and breast cancer. Cancer Causes Control 1992;3:503-512.
119. Potischman N, McCulloch CE, Byers T, Nemoto T, Stubbe N, Milch R, Parker R, Rasmussen KM, Root M, Graham S, Campbell TC. Breast cancer and dietary and plasma concentrations of carotenoids and vitamin A. Am J Clin Nutr 1990;52:909-915.
120. Batieha AM, Armenian HK, Norkus EP, Morris JS, Spate VE, Comstock GW. Serum micronutrients and the subsequent risk of cervical cancer in a population-based nested case-control study. Cancer Epidemiol Biomarkers Prev 1993;2:335-339.
121. Sugerman SB, Mobarhan S, Bowen PE, Stacewicz-Sapuntzakis M, Langenberg P, Henderson C, Kiani R, Friedman H, Lucchesi D. Serum time curve characteristics of a fixed dose of ?-carotene in young and old men. J Am Coll Nutr 1991;10:297-307.
122. Broekmans WM, Klopping-Ketelaars IA, Schuurman CR, Verhagen H, van den Berg H, Kok FJ, van Poppel G. Fruits and vegetables increase plasma carotenoids and vitamins and decrease homocysteine in humans. J Nutr 2000;130:1578-1583.
123. Broekmans WM, Klopping-Ketelaars IA, Weststrate JA, Tijburg LB, van Poppel G, Vink AA, Berendschot TT, Bots ML, Castenmiller WA, Kardinaal AF. Decreased carotenoid concentrations due to dietary sucrose polyesters do not affect possible markers of disease risk in humans. J Nutr 2003;133:720-726.
124. Bowen PE, Mobarhan S, Smith JC. Carotenoid absorption in humans. Methods Enzymol 1993;214:3-17.
125. Chopra M, O'Neill ME, Keogh N, Wortley G, Southon S, Thurnham DI. Influence of increased fruit and vegetable intake on plasma and lipoprotein carotenoids and LDL oxidation in smokers and nonsmokers. Clin Chem 2000;46:1818-1829.
126. Corridan BM, O'Donoghue M, Hughes DA, Morrissey PA. Low-dose supplementation with lycopene or beta-carotene does not enhance cell-mediated immunity in healthy free-living elderly humans. Eur J Clin Nutr 2001;55:627-635.
127. Johnson EJ, Qin J, Krinsky NI, Russell RM. Ingestion by men of a combined dose of beta-carotene and lycopene does not affect the absorption of beta-carotene but improves that of lycopene. J Nutr 1997;127:1833-1837.
128. Koonsvitsky BP, Berry DA, Jones MB, Lin PY, Cooper DA, Jones DY, Jackson JE. Olestra affects serum concentrations of alpha-tocopherol and carotenoids but not vitamin D or vitamin K status in free-living subjects. J Nutr 1997;127(8 Suppl.):1636S-1645S.
129. Martini MC, Campbell DR, Gross MD, Grandits GA, Potter JD, Slavin JL. Plasma carotenoids as biomarkers of vegetable intake: The University of Minnesota Cancer Prevention Research Unit Feeding Studies. Cancer Epidemiol Biomarkers Prev 1995;4:491-496.
130. Maruyama C, Imamura K, Oshima S, Suzukawa M, Egami S, Tonomoto M, Baba N, Harada M, Ayaori M, Inakuma T, Ishikawa T. Effects of tomato juice consumption on plasma and lipoprotein carotenoid concentrations and the susceptibility of low density lipoprotein to oxidative modification. J Nutr Sci Vitaminol 2001;47:213-221.
131. McEligot AJ, Rock CL, Shanks TG, Flatt SW, Newman V, Faerber S, Pierce JP. Comparison of serum carotenoid responses between women consuming vegetable juice and women consuming raw or cooked vegetables. Cancer Epidemiol Biomarkers Prev 1999;8:227-231.
132. Raeini-Sarjaz M, Ntanios FY, Vanstone CA, Jones PJ. No changes in serum fat-soluble vitamin and carotenoid concentrations with the intake of plant sterol/stanol esters in the context of a controlled diet. Metabolism 2002;51:652-656.
133. Scott KJ, Thurnham DI, Hart DJ, Bingham SA, Day K. The correlation between the intake of lutein, lycopene and beta-carotene from vegetables and fruits, and blood plasma concentrations in a group of women aged 50-65 years in the UK. Br J Nutr 1996;75:409-418.
134. Stahl W, Heinrich U, Wiseman S, Eichler O, Sies H, Tronnier H. Dietary tomato paste protects against ultraviolet light-induced erythema in humans. J Nutr 2001;131:1449-1451.
135. Thurmann PA, Steffen J, Zwernemann C, Aebischer CP, Cohn W, Wendt G, Schalch W. Plasma concentration response to drinks containing beta-carotene as carrot juice or formulated as a water dispersible powder. Eur J Nutr 2002;41:228-235.
136. Upritchard JE, Sutherland WH, Mann JI. Effect of supplementation with tomato juice, vitamin E, and vitamin C on LDL oxidation and products of inflammatory activity in type 2 diabetes. Diabetes Care 2000;23:733-738.
137. van der Gaag MS, van den Berg R, van den Berg H, Schaafsma G, Hendriks HF. Moderate consumption of beer, red wine and spirits has counteracting effects on plasma antioxidants in middle-aged men. Eur J Clin Nutr 2000;54:586-591.
138. Wright AJ, Hughes DA, Bailey AL, Southon S. Beta-carotene and lycopene, but not lutein, supplementation changes the plasma fatty acid profile of healthy male non-smokers. J Lab Clin Med 1999;134:592-598.
139. Yeum K-J, Booth SL, Sadowski JA, Liu C, Tang G, Krinsky NI, Russell RM. Human plasma carotenoid response to the ingestion of controlled diets high in fruits and vegetables. Am J Clin Nutr 1996;64:594-602.
140. Coates RJ, Eley JW, Block G, Gunter EW, Sowell AL, Grossman C, Greenberg RS. An evaluation of a food frequency questionnaire for assessing dietary intake of specific carotenoids and vitamin E among low-income black women. Am J Epidemiol 1991;134:658-671.
141. Forman MR, Lanza E, Yong L-C, Holden JM, Graubard BI, Beecher GR, Melitz M, Brown ED, Smith JC. The correlation between two dietary assessments of carotenoid intake and plasma carotenoid concentrations: Application of a carotenoid food-composition database. Am J Clin Nutr 1993;58:519-524.
142. Campbell DR, Gross MD, Martini MC, Grandits GA, Slavin JL, Potter JD. Plasma carotenoids as biomarkers of vegetable and fruit intake. Cancer Epidemiol Biomarkers Prev 1994;3:493-500.
143. Peng Y-M, Peng Y-S, Lin Y, Moon T, Roe DJ, Ritenbaugh C. Concentrations and plasma-tissue diet relationships of carotenoids, retinoids, and tocopherols in humans. Nutr Cancer 1995;23:233-246.
144. Ritenbaugh C, Peng Y-M, Aickin M, Graver E, Branch M, Alberts DS. New carotenoid values for foods improve relationship of food frequency questionnaire intake estimates to plasma values. Cancer Epidemiol Biomarkers Prev 1996;5:907-912.
145. Brady WE, Mares-Perlman JA, Bowen P, Stacewicz-Sapuntzakis M. Human serum carotenoid concentrations are related to physiologic and lifestyle factors. J Nutr 1996;126:129-137.
146. Vandenlangenberg GM, Brady WE, Nebeling LC, Block G, Forman M, Bowen PE, Stacewicz-Sapuntzakis M, Mares-Perlman JA. Influence of using different sources of carotenoid data in epidemiologic studies. J Am Diet Assoc 1996;96:1271-1275.
147. Freeman VL, Meydani M, Yong S, Pyle J, Wan Y, Arvizu-Durazo R, Liao Y. Prostatic levels of tocopherols, carotenoids, and retinol in relation to plasma levels and self-reported usual dietary intake. Am J Epidemiol 2000;151:109-118.
148. Plat J, Mensink RP. Effects of diets enriched with two different plant stanol ester mixtures on plasma ubiquinol-10 and fat-soluble antioxidant concentrations. Metabolism 2001;50:520-529.
149. Food and Nutrition Board, Institute of Medicine, Panel on Dietary Antioxidants and Related Compounds, Subcommittees on Upper Reference Levels of Nutrients and Interpretation and Uses of DRIs, Standing Committee on the Scientific Evaluation of Dietary Reference Intakes, Food and Nutrition Board. Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium and Carotenoids. National Academy Press, Washington, DC, 2000, pp. 456-457.
150. Wei W, Kim Y, Boudreau N. Association of smoking with serum and dietary levels of antioxidants in adults: NHANES III, 1988-1994. Am J Public Health 2001;91:258-264.
151. Chug-Ahuja JK, Holden JM, Forman MR, Mangels AR, Beecher GR, Lanza E. The development and application of a carotenoid database for fruits, vegetables, and selected multicomponent foods. J Am Diet Assoc 1993;93:318-323.
152. Nebeling LC, Forman MR, Graubard BI, Snyder RA. Changes in carotenoid intake in the United States: The 1987 and 1992 National Health Interview Surveys. J Am Diet Assoc 1997;97:991-996.
153. Zhang S, Hunter DJ, Forman MR, Rosner BA, Speizer FE, Colditz GA, Manson JE, Hankinson SE, Willett WC. Dietary carotenoids and vitamins A, C, and E and risk of breast cancer. J Natl Cancer Inst 1999;91:547-556.
154. Food and Nutrition Board, Institute of Medicine, Panel on Micronutrients, Subcommittees on Upper Reference Levels of Nutrients and of Interpretation and Use of Dietary Reference Intakes, and the Standing Committee on the Scientific Evaluation of Dietary Reference Intakes. Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vandium and Zinc. National Academy Press, Washington, DC, 2002, pp. 604-605.
155. Economic Research Service, United States Department of Agriculture. Vegetables and Melons Outlook. United States Department of Agriculture, Washington, DC, Publication VGC-297, June 20, 2003.
156. Sesso HD, Liu S, Gaziano JM, Buring JE. Dietary lycopene, tomato-based food products and cardiovascular disease in women. J Nutr 2003;133:2336-2341.
157. Rock CL, Swendseid ME, Jacob RA, McKee RW. Plasma carotenoid levels in human subjects fed a low carotenoid diet. J Nutr 1992;122:96-100.
158. Riso P, Pinder A, Santangelo A, Porrini M. Does tomato consumption effectively increase the resistance of lymphocyte DNA to oxidative damage? Am J Clin Nutr 1999;69:712-718.
159. American Cancer Society. Cancer Facts and Figures 2003. (51 pages) http://www.cancer.org.
160. Reznikoff CA, Bertram JS, Brankow DW, Heidelberger C. Quantitative and qualitative studies of chemical transformation of cloned C3H mouse embryo cells sensitive to postconfluence inhibition of cell division. Cancer Res 1973;33:3239-3249.
161. Bertram JS, Pung A, Churley M, Kappock TJ 4D, Wilkins LR, Cooney RV. Diverse carotenoids protect against chemically induced neoplastic transformation. Carcinogenesis 1991;12:671-678.
162. Zhang L-X, Cooney RV, Bertram JS. Carotenoids up-regulate connexin 43 gene expression independent of their pro-vitamin A or antioxidant properties. Cancer Res 1992;52:5707-5712.
163. Zhang L-X, Cooney RV, Bertram JS. Carotenoids enhance gap junctional communication and inhibit lipid peroxidation in C3H/10T1/2 cells: Relationship to their cancer chemopreventive action. Carcinogenesis 1991;12:2109-2114.
164. Mehta P, Perez-Stable C, Nadji M, Mian M, Asotra K, Roos BA. Suppression of human prostate cancer cell growth by forced expression of connexin genes. Develop Gene 1999;24:91-110.
165. Livny O, Kaplan I, Reifen R, Polak-Charcon S, Madar Z, Schwartz B. Lycopene inhibits proliferation and enhances gap-junction communication of KB-1 human oral tumor cells. J Nutr 2002;132:3754-3759.
166. Stahl W, von Laar J, Martin HD, Emmerich T, Sies H. Stimulation of gap junctional communication: Comparison of acyclo-retinoic acid and lycopene. Arch Biochem Biophys 2000;373:271-274.
167. Bertram JS. Carotenoids and gene regulation. Nutr Rev 1999;57:182-191.
168. Hotz-Wagenblatt A, Shalloway D. Gap junctional communication and neoplastic transformation. Cit Rev Oncogenesis 1993;4:541-558.
169. Mehta PP, Bertram JS, Loewenstein WR. Growth inhibition of transformed cells correlates with their junctional communication with normal cells. Cell 1986;44:187-196.
170. Loewenstein WR. Junctional intercellular communication and the control of growth. Biochim Biophys Acta 1979;560:1-65.
171. Ames BN, Shigenaga MK, Gold LS. DNA lesions, inducible DNA repair, and cell division: Three key factors in mutagenesis and carcinogenesis. Environ Health Perspect 1993;101(Suppl.):35-44.
172. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990;61:759-767.
173. Wattenberg LW. Inhibition of carcinogenesis by minor dietary constituents. Cancer Res 1992;52(Suppl.):2085s-2091s.
174. Totter JR. Spontaneous cancer and its possible relationship to oxygen metabolism. Proc Natl Acad Sci USA 1980;77:1763-1767.
175. Ames BN, Shigenaga MK, Hagen TM. Oxidants, antioxidants and the degenerative diseases of aging. Proc Natl Acad Sci USA 1993;90:7915-7922.
176. Kasai H. Analysis of a form of oxidative DNA damage, 8-hydroxy-2'-deoxyguanosine, as a marker of cellular oxidative stress during carcinogenesis. Mutat Res 1997;387:146-163.
177. Wang D, Kreutzer DA, Essigmann JM. Mutagenicity and repair of oxidative DNA damage: Insights from studies using defined lesions. Mutat Res 1998;400:99-115.
178. Arashidani K, Iwamoto-Tanaka N, Muraoka M, Kasai H. Genotoxicity of ribo- and deoxyribonucleosides of 8-hydroxyguanine, 5-hydroxycytosine, and 2-hydroxyadenine. Induction of SCE in human lymphocytes and mutagenicity in Salmonella typhimurium TA100. Mutat Res 1998;403:223-227.
179. Fujikawa K, Kamiya H, Kasai H. The mutations induced by oxidatively damaged nucleotides, 5-formyl-dUTP and 5-hydroxy-dCTP, in Escherichia coli. Nucleic Acids Res 1998;26:4582-4587.
180. Halliwell B. Why and how should we measure oxidative DNA damage in nutritional studies? How far have we come? Am J Clin Nutr 2000;72:1082-1087.
181. Di Mascio P, Kaiser S, Sies H. Lycopene as the most efficient biological carotenoid singlet oxygen quencher. Arch Biochem Biophys 1989;274:532-538.
182. Sies H, Stahl W. Lycopene: Antioxidant and biological effects and its bioavailability in the human. Proc Soc Exp Biol Med 1998;218:121-124.
183. Pool-Zobel BL, Bub A, Muller H, Wollowski I, Rechkemmer G. Consumption of vegetables reduces genetic damage in humans: First results of a human intervention trial with carotenoid-rich foods. Carcinogenesis 1997;18:1847-1850.
184. Torbergsen AC, Collins AR. Recovery of human lymphocytes from oxidative DNA damage; the apparent enhancement of DNA repair by carotenoids is probably simply an antioxidant effect. Eur J Nutr 2000;39:80-85.
185. Rehman A, Bourne LC, Halliwell B, Rice-Evans CA. Tomato consumption modulates oxidative DNA damage in humans. Biochem Biophys Res Commun 1999;262:828-831.
186. Lavelli V, Peri C, Rissolo A. Antioxidant activity of tomato products as studied by model reactions using xanthine oxidase, myeloperoxidase, and copper-induced lipid peroxidation. J Agric Food Chem 2000;48:1442-1448.
187. Colditz GA, Branch LG, Lipnick RJ, Willett WC, Rosner B, Posner BM, Hennekens CH. Increased green and yellow vegetable intake and lowered cancer deaths in an elderly population. Am J Clin Nutr 1985;41:32-36.
188. Sakr WA. Prostatic intraepithelial neoplasia: A marker for high-risk groups and a potential target for chemoprevention. Eur Urol 1999;35:474-478.
189. Bostwick DG, Brawer MK. Prostate intra-epithelial neoplasia and early invasion in prostate cancer. Cancer 1987;59:788-794.
190. Bostwick DG, Pacelli A, Lopez Beltran A. Ultrastructure of prostatic intraepithelial neoplasia. Prostate 1997;33:32-37.
191. McNeal JE, Villers A, Redwine EA, Freiha FS, Stamey TA. Microcarcinoma in the prostate: Its association with duct-acinar dysplasia. Hum Pathol 1991;22:644-652.
192. Willis MS, Wians FH Jr. The role of nutrition in preventing prostate cancer: A review of the proposed mechanism of action of various dietary substances. Clin Chim Acta 2003;330:57-83.
193. Pathak SK, Sharma RA, Mellon JK. Chemoprevention of prostate cancer by diet-derived antioxidant agents and hormonal manipulation (Review). Int J Oncol 2003;22:5-13.
194. Nelson PS, Montgomery B. Unconventional therapy for prostate cancer: Good, bad or questionable? Nat Rev Cancer 2003;3:845-858.
195. Malins DC, Polissar NL, Gunselman SJ. Models of DNA structure achieve almost perfect discrimination between normal prostate, benign prostatic hyperplasia (BPH), and adenocarcinoma and have a high potential for predicting BPH and prostate cancer. Proc Natl Acad Sci USA 1997;94:259-264.
196. Malins DC, Johnson PM, Wheeler TM, Barker EA, Polissar NL, Vinson MA. Age-related radical-induced DNA damage is linked to prostate cancer. Cancer Res 2001;61:6025-6028.
197. Jones JI, Clemmons DR. Insulin-like growth factors and their binding proteins: Biological actions. Endocr Rev 1995;16:3-34.
198. Cohen P, Peehl DM, Rosenfeld RG. The IGF axis in the prostate. Hormone Metab Res 1994;26:81-84.
199. Yu H, Rohan T. Role of the insulin-like growth factor family in cancer development and progression. J Natl Cancer Inst 2000;92:1472-1489.
200. Cohen P, Peehl DM, Lamson G, Rosenfeld RG. Insulin-like growth factors (IGFs), IGF receptors, and IGF-binding proteins in primary cultures of prostate epithelial cells. J Clin Endocrinol Metab 1991;73:401-407.
201. Pollak M, Beamer W, Zhang JC. Insulin-like growth factors and prostate cancer. Cancer Met Rev 1998-1999;17:383-390.
202. Cohen SM, Ellwein LB. Cell proliferation in carcinogenesis. Science 1990;249:1007-1011.
203. Butterworth BE, Goldsworthy TL. The role of cell proliferation in multistage carcinogenesis. Proc Soc Exptl Biol Med 1991;198:683-687.
204. Chan JM, Stampfer MJ, Giovannucci E, Gann PH, Ma J, Wilkinson P, Hennekens CH, Pollak M. Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study. Science 1998;279:563-566.
205. Mantzoros CS, Tzonou A, Signorello LB, Stampfer M, Trichopoulos D, Adami HO. Insulin-like growth factor-1 in relation to prostate cancer and benign prostatic hyperplasia. Br J Cancer 1997;76:1115-1118.
206. Wolk A, Mantzoros CS, Andersson SO, Bergstrom R, Signorello LB, Lagiou P, Adami HO, Trichopoulos D. Insulin-like growth factor-1 and prostate cancer risk: A population-based, case-control study. J Natl Cancer Inst 1998;90:911-915.
207. Kim L, Rao AV, Rao LG. Effect of lycopene on prostate LNCaP cancer cells in culture. J Med Food 2002;5:181-187.
208. Kotake-Nara E, Kushiro M, Zhang H, Sugawara T, Miyashita K, Nagao A. Carotenoids affect proliferation of human prostate cancer cells. J Nutr 2001;131:3303-3306.
209. Pastori M, Pfander H, Boscoboinik D, Azzi A. Lycopene in association with alpha-tocopherol inhibits at physiological concentrations proliferation of prostate carcinoma cells. Biochem Biophys Res Commun 1998;250:582-585.
210. Kucuk O, Sarkar FH, Djuric Z, Sakr W, Pollak MN, Khachik F, Banerjee M, Bertram JS, Wood DP Jr. Effects of lycopene supplementation in patients with localized prostate cancer. Exp Biol Med 2002;227:881-885.
211. Van Breemen RB, Xu X, Viana MA, Chen L, Stacewicz-Sapuntzakis M, Duncan C, Bowen PE, Sharifi R. Liquid chromatography-mass spectrometry of cis- and all-trans-lycopene in human serum and prostate tissue after dietary supplementation with tomato sauce. J Agric Food Chem 2002;50:2214-2219.
212. Giovannucci E, Ascherio A, Rimm EB, Stampfer MJ, Colditz GA, Willett WC. Intake of carotenoids and retinol in relation to risk of prostate cancer. J Natl Cancer Inst 1995;87:1767-1776.
213. Giovannucci E, Rimm EB, Liu Y, Stampfer MJ, Willett WC. A prospective study of tomato products, lycopene, and prostate cancer risk. J Natl Cancer Inst 2002;94:391-398.
214. Mills PK, Beeson WL, Phillips RL, Fraser GE. Positive associations between dietary intake of lycopene and prostate cancer. Cohort study of diet, lifestyle, and prostate cancer in Adventist men. Cancer 1989;64:598-604.
215. Cerhan J, Chiu B, Putnam S, Parker A, Robbins M, Lynch C, Cantor K, Torner J, Wallace R. A cohort study of diet and prostate cancer risk (abstract). Cancer Epidemiol Biomarkers Prev 1998;7:175.
216. Grant WB. An ecologic study of dietary links to prostate cancer. Altern Med Rev 1999;4:162-169.
217. Miller EC, Giovannucci E, Erdman JW Jr, Bahnson R, Schwartz SJ, Clinton SK. Tomato products, lycopene, and prostate cancer risk. Urol Clin North Am 2002;29:83-93.
218. Tzonou A, Signorello LB, Lagiou P, Wuu J, Trichopoulos D, Trichopoulou A. Diet and cancer of the prostate: A case-control study in Greece. Int J Cancer 1999;80:704-708.
219. Jain MG, Hislop GT, Howe GR, Ghadirian P. Plant foods, antioxidants, and prostate cancer risk: Findings from case-control studies in Canada. Nutr Cancer 1999;34:173-184.
220. van Gils CH, Bostick RM, Stern MC, Taylor JA. Differences in base excision repair capacity may modulate the effect of dietary antioxidant intake on prostate cancer risk: an example of polymorphisms in the XRCC1 gene. Cancer Epidemiol Biomarkers Prev 2002;11:1279-1284.
221. Fleshner N, Agarwal S, Rao V. Serum and tissue lycopene and biomarkers of oxidation in prostate cancer patients: A case control study (abstract). Prostate Cancer Prostatic Dis 2000;3(Suppl. 1):S13.
222. Mucci LA, Tamimi R, Lagiou P, Trichopoulou A, Benetou V, Spanos E, Trichopoulos D. Are dietary influences on the risk of prostate cancer mediated through the insulin-like growth factor system? BJU Int 2001;87:814-820.
223. Matlaga BR, Hall MC, Stindt D, Torti FM. Response of hormone refractory prostate cancer to lycopene. J Urol 2001;166:613.
224. Key TJ, Silcocks PB, Davey GK, Appleby PN, Bishop DT. A case-control study of diet and prostate cancer. Br J Cancer 1997;76:678-687.
225. Cohen JH, Kristal AR, Stanford JL. Fruit and vegetable intakes and prostate cancer risk. J Natl Cancer Inst 2000;92:61-68.
226. Hayes RB, Ziegler RG, Gridley G, Swanson C, Greenberg RS, Swanson GM, Schoenberg JB, Silverman DT, Brown LM, Pottern LM, Liff J, Schwartz AG, Fraumeni JF Jr, Hoover RN. Dietary factors and risks for prostate cancer among blacks and whites in the United States. Cancer Epidemiol Biomarkers Prev 1999;8:25-34.
227. Schuurman AG, Goldbohm RA, Brants HA, van den Brandt PA. A prospective cohort study on intake of retinol, vitamins C and E, and carotenoids and prostate cancer risk (Netherlands). Cancer Causes Control 2002;13:573-582.
228. Norrish AE, Jackson RT, Sharpe SJ, Skeaff CM. Prostate cancer and dietary carotenoids. Am J Epidemiol 2000;151:119-123.
229. Schuurman AG, Goldbohm RA, Dorant E, van den Brandt PA. Vegetable and fruit consumption and prostate cancer risk: A cohort study in the Netherlands. Cancer Epidemiol Biomarkers Prev 1998;7:673-680.
230. Kolonel LN, Hankin JH, Whittemore AS, Wu AH, Gallagher RP, Wilkens LR, John EM, Howe GR, Dreon DM, West DW, Paffenbarger RS Jr. Vegetables, fruits, legumes and prostate cancer: A multi-ethnic case-control study. Cancer Epidemiol Biomarkers Prev 2000;9:795-804.
231. Le Marchand L, Hankin JH, Kolonel LN, Wilkens LR. Vegetable and fruit consumption in relation to prostate cancer risk in Hawaii: a reevaluation of the effect of dietary beta-carotene. Am J Epidemiol 1991;133:215-219.
232. Meyer F, Bairati I, Fradet Y, Moore L. Dietary energy and nutrients in relation to preclinical prostate cancer. Nutr Cancer 1997;29:120-126.
233. Hsing AW, Comstock GW, Abbey H, Polk BF. Serologic precursors of cancer. Retinol, carotenoids, and tocopherol and risk of prostate cancer. J Natl Cancer Inst 1990;82:941-946.
234. Comstock GW, Helzlsouer KJ, Bush TL. Prediagnostic serum levels of carotenoids and vitamin E as related to subsequent cancer in Washington County, Maryland. Am J Clin Nutr 1991;53(Suppl.):260S-264S.
235. Pohar KS, Gong MC, Bahnson R, Miller EC, Clinton SK. Tomatoes, lycopene and prostate cancer: A clinician's guide for counseling those at risk for prostate cancer. World J Urol 2003;21:9-14.
236. Arab L, Steck-Scott S, Bowen P. Participation of lycopene and beta-carotene in carcinogenesis: defenders, aggressors, or passive bystanders? Epidemiol Rev 2001;23:211-230.
237. Arab L, Steck-Scott S, Fleishauer AT. Lycopene and the lung. Exp Biol Med 2002;227:894-899.
238. Samet JM, Hatch GE, Horstman D, Steck-Scott S, Arab L, Bromberg PA, Levine M, McDonnell W, Devlin RB. Effect of antioxidant supplementation on ozone-induced lung injury in human subjects. Am J Respir Crit Care Med 2001;164:819-825.
239. Steck SE, Madden M, Samet J, Arab L. The prevention of ozone-induced DNA damage in human lung epithelial cells by dietary antioxidants (abstract). FASEB J 2000;14:4.
240. Steck SE, Samet J, Craft N, Kohlmeier L. Correlation between lung macrophage and plasma carotenoid levels in humans (abstract). FASEB J 1999;13:14.
241. Giovanucci E. Insulin-like growth factor-1 and binding protein-3 and risk of cancer. Horm Res 1999;51(Suppl. 3):34-41.
242. Levy J, Bosin E, Feldman B, Giat Y, Miinster A, Danilenko M, Sharoni Y. Lycopene is a more potent inhibitor of human cancer cell proliferation than either alpha-carotene or beta-carotene. Nutr Cancer 1995;24:257-266.
243. Liu C, Lian F, Smith DE, Russell RM, Wang XD. Lycopene supplementation inhibits lung squamous metaplasia and induces apoptosis via up-regulating insulin-like growth factor-binding protein 3 in cigarette smoke-exposed ferrets. Cancer Res 2003;63:3138-3144.
244. Kim DJ, Takasuka N, Kim JM, Sekine K, Ota T, Asamoto M, Murakoshi M, Nishino H, Nir Z, Tsuda H. Chemoprevention by lycopene of mouse lung neoplasia after combined initiation treatment with DEN, MNU and DMH. Cancer Lett 1997;120:15-22.
245. Holick CN, Michaud DS, Stolzenberg-Solomon R, Mayne ST, Pietinen P, Taylor PR, Virtamo J, Albanes D. Dietary carotenoids, serum beta-carotene, and retinol and risk of lung cancer in the alpha-tocopherol, beta-carotene cohort study. Am J Epidemiol 2002;156:536-547.
246. Michaud DS, Feskanich D, Rimm EB, Colditz GA, Speizer FE, Willett WC, Giovannucci E. Intake of specific carotenoids and risk of lung cancer in 2 prospective US cohorts. Am J Clin Nutr 2000;72:990-997.
247. Goodman MT, Kolonel LN, Wilkins LR, Yoshizawa CN, Le Marchand L, Hankin JH. Dietary factors in lung cancer prognosis. Eur J Cancer 1992;28:495-501.
248. Le Marchand, L, Yoshizawa CN, Kolonel LN, Hankin JH, Goodman MT. Vegetable consumption and lung cancer risk: A population-based case-control study in Hawaii. J Natl Cancer Inst 1989;81:1158-1164.
249. Brennan P, Fortes C, Butler J, Agudo A, Benhamou S, Darby S, Gerken M, Jockel K-H, Kreuzer M, Mallone S, Nyberg F, Pohlabein H, Ferro G, Boffetta P. A multi-center case-control study of diet and lung cancer among non-smokers. Cancer Causes Control 2000;11:49-58.
250. Agudo A, Esteve MG, Pallares C, Martinez-Ballarin I, Fabregat X, Malats N, Machengs I, Badia A, Gonzalez CA. Vegetable and fruit intake and the risk of lung cancer in women in Barcelona. Spain Eur J Cancer 1997;33:1256-1261.
251. Forman MR, Yao SX, Graubard BI, Qiao YL, McAdams M, Mao BL, Taylor PR. The effect of dietary intake of fruits and vegetables on the odds ratio of lung cancer among Yunnan tin miners. Int J Epidemiol 1992;21:437-441.
252. Li Y, Elie M, Blaner WS, Brandt-Rauf P, Ford J. Lycopene, smoking and lung cancer (abstract). Proc Am Assoc Cancer Res 1997;38:A758.
253. Le Marchand, L, Hankin JH, Kolonel LN, Beecher GR, Wilkens LR, Zhao LP. Intake of specific carotenoids and lung cancer risk. Cancer Epidemiol Biomarkers Prev 1993;2:183-187.
254. Voorrips LE, Goldbohm RA, Brants HA, van Poppel GA, Sturmans F, Hermus RJ, van den Brandt PA. A prospective cohort study on antioxidant and folate intake and male lung cancer risk. Cancer Epidemiol Biomarkers Prev 2000;9:357-365.
255. Knect P, Jarvinen R, Teppo L, Aromaa A, Seppanen R. Role of various carotenoids in lung cancer prevention. J Natl Cancer Inst 1999;91:182-184.
256. Kvale, G, Bjelke E, Gart JJ. Dietary habits and lung cancer risk. Int J Cancer 1983;31:397-405.
257. Speizer FE, Colditz GA, Hunter DJ, Rosner B, Hennekens C. Prospective study of smoking, antioxidant intake, and lung cancer in middle-aged women (USA). Cancer Causes Control 1999;10:475-482.
258. Fraser GE, Beeson L, Phillips RL. Diet and lung cancer in California Seventh-Day Adventists. Am J Epidemiol 1991;133:683-693.
259. Garcia-Closas R, Agudo A, Gonzalez CA, Riboli E. Intake of specific carotenoids and flavonoids and the risk of lung cancer in women in Barcelona, Spain. Nutr Cancer 1998;32:154-158.
260. de Stefani E, Boffetta P, Deneo-Pellegrini H, Mendilaharsu M, Carzoglio JC, Ronco A, Olivera L. Dietary antioxidants and lung cancer risk: A case-control study in Uruguay. Nutr Cancer 1999;34:100-110.
261. Knekt P, Jarvinen R, Seppanen R, Rissanen A, Aromaa A, Heinonen OP, Albanes D, Heinonen M, Pukkala E, Teppo L. Dietary antioxidants and the risk of lung cancer. Am J Epidemiol 1991;134:471-479.
262. Harris RW, Key TJ, Silcocks PB, Bull D, Wald NJ. A case-control study of dietary carotene in men with lung cancer and in men with other epithelial cancers. Nutr Cancer 1991;15:63-68.
263. Swanson CA, Mao BL, Li JY, Lubin JH, Yao SX, Wang JZ, Cai SK, Hou Y, Luo QS, Blot WJ. Dietary determinants of lung cancer risk: Results from a case-control study in Yunnan Province. China Int J Cancer 1992;50:876-880.
264. Steinmetz KA, Potter JD, Folsom AR. Vegetables, fruit, and lung cancer in the Iowa Women's Health Study. Cancer Res 1993;53:536-543.
265. Axelsson G, Liljeqvist T, Andersson L, Bergman B, Rylander R. Dietary factors and lung cancer among men in west Sweden. Int J Epidemiol 1996;25:32-39.
266. Mayne ST, Janerich DT, Greenwald P, Chorost S, Tucci C, Zaman MB, Melamed MR, Kiely M, McKneally MF. Dietary ?-carotene and lung cancer risk in U.S. nonsmokers. J Natl Cancer Inst 1994;86:33-38.
267. Candelora EC, Stockwell HG, Armstrong AW, Pinkham PA. Dietary intake and risk of lung cancer in women who never smoked. Nutr Cancer 1992;17:263-270.
268. Bond GG, Thompson FE, Cook RR. Dietary vitamin A and lung cancer: Results of a case-control study among chemical workers. Nutr Cancer 1987;9:109-121.
269. Rohan TE, Jain M, Howe GR, Miller AB. A cohort study of dietary carotenoids and lung cancer risk in women (Canada). Cancer Causes Control 2002;13:231-237.
270. Ziegler RG, Colavito EA, Hartge P, McAdams MJ, Schoenberg JB, Mason TJ, Fraumeni JF Jr. Importance of ?-carotene, ?-carotene and other phytochemicals in the etiology of lung cancer. J Natl Cancer Inst 1996;81:612-614.
271. Sankaranarayanan R, Varghese C, Duffy SE, Padmakumary G, Day NE, Nair MK. A case-control study of diet and lung cancer in Kerala, south India. Int J Cancer 1994;58:644-649.
272. Marilley D, Vonlanthen S, Gioria A, Schwaller B. Calretinin and calretinin-22k increase resistance toward sodium butyrate-induced differentiation in CaCo-2 colon adenocarcinoma cells. Exp Cell Res 2001;268:93-103.
273. Gordon JI, Schmidt GH, Roth KA. Studies of intestinal stem cells using normal, chimeric and transgenic mice. FASEB J 1992;6:3039-3050.
274. Eastwood GL. A review of gastrointestinal epithelial renewal and its relevance to the development of adenocarcinomas of the gastrointestinal tract. J Clin Gastroenterol 1995;21(Suppl. 1):S1-S11.
275. Schmidt GH, Wilkinson MM, Ponder BA. Cell migration pathway in the intestinal epithelium: An in situ marker system using mouse aggregation chimeras. Cell 1985;40:425-429.
276. Wright NA, Irwin M. The kinetics of villus cell populations in the mouse small intestine. I. Normal villi: The steady state requirement. Cell Tissue Kinet 1982;15:595-609.
277. Whitfield JF, Bird RP, Chakravarthy BR, Isaacs RJ, Morley P. Calcium - Cell cycle regulator, differentiator, killer, chemopreventor, and maybe, tumor promoter. J Cell Biochem Suppl 1995;22:74-91.
278. Kerr JFR, Wyllie AH, Currie AR. Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972;26:239-257.
279. Arends MJ, Wyllie AH. Apoptosis: Mechanisms and roles in pathology. Int Rev Exp Pathol 1991;32:223-254.
280. Patel T, Gores GJ, Kaufmann SH. The role of proteases during apoptosis. FASEB J 1996;10:587-597.
281. Arends MJ, Morris RG, Wyllie AH. Apoptosis: The role of the endonuclease. Am J Pathol 1990;136:593-608.
282. Raff M. Cell suicide for beginners. Nature 1998;396:119-122.
283. Richter C. Pro-oxidants and mitochondrial Ca2+: Their relationship to apoptosis and oncogenesis. FEBS Lett 1993;325:104-107.
284. Lemasters JJ, Nieminen AL, Qian T, Trost LC, Elmore SP, Nishimura Y, Crowe RA, Cascio WE, Bradham CA, Brenner DA, Herman B. The mitochondrial permeability transition in cell death: A common mechanism in necrosis, apoptosis and autophagy. Biochem Biophys Acta 1998;1366:177-196.
285. Zamzami N, Kroemer G. The mitochondrion in apoptosis: How Pandora's box opens. Nat Rev Mol Cell Biol 2001;2:67-71.
286. Krishnan K, Brenner DE. Chemoprevention of colorectal cancer. Gastroenterol Clin North Am 1996;25:821-858.
287. Sporn MB. Approaches to prevention of epithelial cancer during the preneoplastic period. Cancer Res 1976;36:2699-2702.
288. Gwyn K, Sinicrope FA. Chemoprevention of colorectal cancer. Am J Gastroenterol 2002;97:13-21.
289. Bodmer WF, Bailey CJ, Bodmer J, Bussey HJR, Ellis A, Gorman P, Lucibello FC, Murday VA, Rider SH, Scambler P, Sheer D, Solomon E, Spurr NK. Localization of the gene for familial adenomatous polyposis in chromosome 5. Nature 1987;328:614-616.
290. Leppert M, Dobbs M, Scambler P, O'Connell P, Nakamura Y, Stauffer D, Woodward S, Burt R, Hughes J, Gardner E, Lathrop M, Wasmuth J, Lalouel J-M, White R. The gene for familial polyposis coli maps to the long arm of chromosome 5. Science 1987;238:1411-1413.
291. Groden J, Thliveris A, Samowitz W, Carlson M, Gelbert L, Albertsen H, Joslyn G, Stevens J, Spirio L, Robertson M, Sargeant L, Krapcho K, Wolff E, Burt R, Hughes JP, Warrington J, McPherson J, Wasmuth J, Le Paslier D, Abderrahim H, Cohen D, Leppert M, White R. Identification and characterization of the familial adenomatous polyposis coli gene. Cell 1991;66:589-600.
292. Nathke IS, Adams CL, Polakis P, Sellin JH, Nelson WJ. The adenomatous polyposis coli tumor suppressor protein localizes to plasma membrane sites involved in active cell migration. J Cell Biol 1996;134:165-179.
293. Barth AI, Nathke IS, Nelson WJ. Cadherins, catenins and APC protein: Interplay between cytoskeletal complexes and signaling pathways. Curr Opinions Cell Biol 1997;9:683-690.
294. Kinzler KW, Vogelstein B. Lessons from hereditary colorectal cancer. Cell 1996;87:159-170.
295. Potter JD. Colorectal cancer: Molecules and populations. J Natl Cancer Inst 1999;91:916-932.
296. Houlston RS. What we could do now: Molecular pathology of colorectal cancer. J Clin Pathol Mol Pathol 2001;54:206-214.
297. Bartram H-P, Scheppach W, Schmid H, Hofmann A, Dusel G, Richter F, Richter A, Kasper H. Proliferation of human colonic mucosa as an intermediate biomarker of carcinogenesis: Effects of butyrate, deoxycholate, calcium, ammonia, and pH. Cancer Res 1993;53:3283-3288.
298. Govers MJ, Termont DS, Van der Meer R. Mechanism of the antiproliferative effect of milk mineral and other calcium supplements on colonic epithelium. Cancer Res 1994;54:95-100.
299. Newmark HL, Lipkin M, Maheshwari N. Colonic hyperproliferation induced in rats and mice by nutritional-stress diets containing four components of a human Western-style diet (Series 2). Am J Clin Nutr 1991;54:209s-214s.
300. Bird RP, Schneider R, Stamp D, Bruce WR. Effect of dietary calcium and cholic acid on the proliferative indices of murine colonic epithelium. Carcinogenesis 1986;7:1657-1661.
301. Wargovich MJ, Eng VWS, Newmark HL, Bruce WR. Calcium ameliorates the toxic effect of deoxycholic acid on colonic epithelium. Carcinogenesis 1983;4:1205-1207.
302. Wargovich MJ, Eng VWS, Newmark HL. Calcium inhibits the damaging and compensatory proliferative effects of fatty acids on mouse colon epithelium. Cancer Lett 1984;23:253-258.
303. McLellan EA, Bird RP. Aberrant crypts: Potential preneoplastic lesions in the murine colon. Cancer Res 1988;48:6187-6192.
304. Bird RP. Observations and quantification of aberrant crypts in the murine colon treated with a colon carcinogen: Preliminary findings. Cancer Lett 1987;37:147-151.
305. Correa P. Epidemiology of polyps and cancer. Major Prob Pathol 1978;10:126-152.
306. Hill MJ. Etiology of the adenoma-carcinoma sequence. Major Prob Pathol 1978;10:153-162.
307. Kendall CW, Janezic SA, Friday D, Venket Rao A. Dietary cholesterol enhances preneoplastic aberrant crypt formation and alters cell proliferation in the murine colon treated with azoxymethane. Nutr Cancer 1992;17:107-114.
308. Magnuson BA, Carr I, Bird RP. Ability of aberrant crypt characteristics to predict colonic tumour incidence in rats fed cholic acid. Cancer Res 1993;53:4499-4504.
309. Pretlow TP, Barrow BJ, Ashton WS, O'Riordan MA, Pretlow TG, Jurcisek JA, StellatoTA. Aberrant crypts: Putative preneoplastic foci in human colonic mucosa. Cancer Res 1991;51:1564-1567.
310. Pretlow TP, O'Riordan MA, Somich GA, Amini SB, Pretlow TG. Aberrant crypts correlate with tumour incidence in F344 rats treated with azoxymethane and phytate. Carcinogenesis 1992;13:1509-1512.
311. Rao CV, Desai D, Simi B, Kulkarni N, Amin S, Reddy BS. Inhibitory effect of caffeic acid esters on azoxymethane-induced biochemical changes and aberrant crypt foci formation in rat colon. Cancer Res 1993;53:4182-4188.
312. Shivapurkar N, Tang ZC, Frost A, Alabaster O. Inhibition of progression of aberrant crypt foci and colon tumour development by vitamin E and ?-carotene in rats on a high-risk diet. Cancer Lett 1995;91:125-132.
313. Zarkovic M, Qin X, Nakatsuru Y, Oda H, Nakamura T, Shamsuddin AM, Ishikawa T. Tumour promotion by fecapentaene-12 in a rat colon carcinogenesis model. Carcinogenesis 1993;14:1261-1264.
314. Bird RP. Role of aberrant crypt foci in understanding the pathogenesis of colon cancer. Cancer Lett 1995;93:55-71.
315. Pretlow TP, O'Riordan MA, Pretlow TG, Stellato TA. Aberrant crypts in human colon mucosa: Putative preneoplastic lesions. J Cell Biochem 1992;(Suppl. 16G):55-62.
316. Wargovich MJ, Harris C, Chen D, Palmer C, Steele VE, Kelloff GJ. Growth kinetics and chemoprevention of aberrant crypts in the rat colon. J Cell Biochem 1992;(Suppl. 16G):51-54.
317. Richards TC. Changes in crypt cell populations of mouse colon during recovery from treatment with 1,2-dimethylhydrazine. J Natl Cancer Inst 1981;66:907-912.
318. Barsoum GH, Thompson H, Neoptolemos JP, Keighley MR. Dietary calcium does not reduce experimental colorectal carcinogenesis after small bowel resection despite reducing cellular proliferation. Gut 1992;33:1515-1520.
319. Behling AR, Kaup SM, Greger JL. Changes in intestinal function of rats initiated with DMH and fed varying levels of butterfat, calcium, and magnesium. Nutr Cancer 1990;13:189-199.
320. Hambly RJ, Rumney CJ, Cunninghame M, Fletcher JM, Rijken PJ, Rowland IR. Influence of diets containing high and low risk factors for colon cancer on early stages of carcinogenesis in human flora-associated (HFA) rats. Carcinogenesis 1997;18:1535-1539.
321. Liu Z, Tomotake H, Wan G, Watanabe H, Kato N. Combined effect of dietary calcium and iron on colonic aberrant crypt foci, cell proliferation and apoptosis, and fecal bile acids in 1,2-dimethylhydrazine-treated rats. Oncol Rep 2001;8:893-897.
322. Belleli A, Shany S, Levy J, Guberman R, Lamprecht SA. A protective role of 1,25-dihydroxyvitamin D3 in chemically induced rat colon carcinogenesis. Carcinogenesis 1992;13:2293-2298.
323. Barthold SW, Beck D. Modification of early dimethylhydrazine carcinogenesis by colonic mucosa hyperplasia. Cancer Res 1980;40:4451-4455.
324. Pence BC, Buddingh F. Inhibition of dietary fat-promoted colon carcinogenesis in rats by supplemental calcium or vitamin D3. Carcinogenesis 1988;9:187-190.
325. Moorghen M, Ince P, Finney KJ, Sunter JP, Appleton D, Watson AJ. A protective effect of sulindac against chemically-induced primary colonic tumors in mice. J Pathol 1988;156:341.
326. Sitrin MD, Halline AG, Abrahams C, Brasitus TA. Dietary calcium and vitamin D modulate 1,2-dimethylhydrazine-induced colonic carcinogenesis in the rat. Cancer Res 1991;51:5608-5613.
327. Ahnen J. Are animal models of colon cancer relevant to human diseases? Dig Dis Sci 1985;30:103S-106S.
328. Chang WWL. Histogenesis of colon cancer in experimental animals. Scand J Gastroenterol 1984;19(Suppl. 104):27-43.
329. Appleton GV, Bristol JB, Williamson RC. Increased dietary calcium and small bowel resection have opposite effects on colonic cell turnover. Br J Surg 1986;73:1018-1021.
330. Li H, Kramer PM, Lubet RA, Steele VE, Kelloff GJ, Pereira MA. Effect of calcium on azoxymethane-induced aberrant crypt foci and cell proliferation in the colon of rats. Cancer Lett 1998;124:39-46.
331. Tao L, Kramer PM, Wang W, Yang S, Lubet RA, Steele VE, Pereira MA. Altered expression of c-myc, p16 and p27 in rat colon tumors and its reversal by short-term treatment with chemopreventive agents. Carcinogenesis 2002;23:1447-1454.
332. Molck A-M, Poulsen M, Meyer O. The combination of 1alpha,25(OH2)-vitamin D3, calcium and acetylsalicylic acid affects azoxymethane-induced aberrant crypt foci and colorectal tumours in rats. Cancer Lett 2002;186:19-28.
333. Thiagarajan DG, Bennink MR, Bourquin LD, Kavas FA. Prevention of precancerous colonic lesions in rats by soy flakes, soy flour, genistein, and calcium. Am J Clin Nutr 1998;68(6 Suppl):1394S-1399S.
334. Wargovich MJ, Jimenez A, McKee K, Steele VE, Velasco M, Woods J, Price R, Gray K, Kelloff GJ. Efficacy of potential chemopreventive agents on rat colon aberrant crypt formation and progression. Carcinogenesis 2000;21:1149-1155.
335. Appleton GV, Davies PW, Bristol JB, Williamson RC. Inhibition of intestinal carcinogenesis by dietary supplementation with calcium. Br J Surg. 1987;74:523-525.
336. Pereira MA, Barnes LH, Rassman VL, Kelloff GV, Steele VE. Use of azoxymethane-induced foci of aberrant crypts in rat colon to identify potential cancer chemopreventive agents. Carcinogenesis 1994;15:1049-1054.
337. Skrypec DJ, Bursey RG. Effect of dietary calcium on azoxymethane-induced intestinal carcinogenesis in male F 344 rats fed high fat diets (abstract). FASEB 1988;2:A857.
338. Pence BC, Dunn DM, Zhao C, Landers M, Wargovich MJ. Chemopreventive effects of calcium but not aspirin supplementation in cholic acid-promoted colon carcinogenesis: Correlation with intermediate endpoints. Carcinogenesis 1995;16:757-765.
339. Wargovich MJ, Allnutt D, Palmer C, Anaya P, Stephens LC. Inhibition of the promotional phase of azoxymethane-induced colon carcinogenesis in the F344 rat by calcium lactate: Effect of simulating two human nutrient density levels. Cancer Lett 1990;53:17-25.
340. Belbraouet S, Felden F, Pelletier X, Gastin I, Lambert D, Floquet J, Gueant JL, Debry G. Dietary calcium salts as protective agents and laminin P1 as a biochemical marker in chemically induced colon carcinogenesis in rats. Cancer Detect Prev 1996;20:294-299.
341. McSherry CK, Cohen BI, Bokkenheuser VD, Mosbach EH, Winter J, Matoba N, Scholes J. Effects of calcium and bile acid feeding on colon tumors in the rat. Cancer Res 1989;49:6039-6043.
342. Quilliot D, Belbraouet S, Pelletier X, Gueant JL, Floquet J, Debry G. Influence of a high-calcium carbonate diet on the incidence of experimental colon cancer in rats. Nutr Cancer 1999;34:213-219.
343. Bedi A, Pasricha PJ, Akhtar AJ, Barber JP, Bedi GC, Giardello FM, Zehnbauer BA, Hamilton SR, Jones RJ. Inhibition of apoptosis during development of colorectal cancer. Cancer Res 1995;55:1811-1816.
344. Boland CR. The biology of colorectal cancer: Implications for pretreatment and follow-up management. Cancer 1993;71:4180-4186.
345. Fearon ER. Molecular genetic studies of the adenoma-carcinoma sequence. Adv Intern Med 1994;39:123-147.
346. Rustgi AK. Molecular genetics and colorectal cancer. Gastroenterology 1993;104:1223-1225.
347. Greenwald P, Kelloff GJ, Boone CW, McDonald SS. Genetic and cellular changes in colorectal cancer: Proposed targets of chemopreventive agents. Cancer Epidemiol Biomarkers Prev 1995;4:691-702.
348. Eshleman JR, Markowitz SD. Microsatellite instability in inherited and sporadic neoplasms. Curr Opin Oncol 1995;7:83-89.
349. Thibodeau SN, Bren G, Schaid D. Microsatellite instability in cancer of the proximal colon. Science 1993;260:816-819.
350. Tsao JL, Dudley S, Kwok B, Nickel AE, Laird PW, Siegmund KD, Liskay RM, Shibata D. Diet, cancer and aging in DNA mismatch repair deficient mice. Carcinogenesis 2002;23:1807-1810.
351. Liu B, Nicolaides NC, Markowitz S, Willson JK, Parsons RE, Jen J, Papadopolous N, Peltomaki P, de la Chapelle A, Hamilton SR. Mismatch repair gene defects in sporadic colorectal cancers with microsatellite instability. Nature Genet 1995;9:48-55.
352. Aaltonen LA, Peltomaki P, Leach FS, Sistonen P, Pylkkanen L, Mecklin J-P, Jarvinen H, Powell SM, Jen J, Hamilton SR, Petersen GM, Kinzler KW, Vogelstein B, de la Chapelle A. Clues to the pathogenesis of familial colorectal cancer. Science 1993;260:812-816.
353. Marra G, Boland CR. Hereditary nonpolyposis colorectal cancer: The syndrome, the genes, and historical perspectives. J Natl Cancer Inst 1995;87:1114-1125.
354. Peltomaki P, Vasen HF. Mutations predisposing to hereditary nonpolyposis colorectal cancer: Database and results of a collaborative study. The International Collaborative Group on Hereditary Nonpolyposis Colorectal Cancer. Gastroenterology 1997;113:1146-1158.
355. Bronner CE, Baker SM, Morrison PT, Warren G, Smith LG, Lescoe MK, Kane M, Earabino C, Lipford J, Lindblom A. Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary non-polyposis colon cancer. Nature 1994;368:258-261.
356. Fishel R, Lescoe MK, Rao MR, Copeland NG, Jenkins NA, Garber J, Kane M, Kolodner R. Human mutator gene homologue (hMSH-2) and its association with hereditary non-polyposis colon cancer. Cell 1993;75:1027-1038.
357. Reshef R, Rozen P, Fireman Z, Fine N, Barzilai M, Shasha SM, Shkolnik T. Effect of a calcium-enriched diet on the colonic epithelial hyperproliferation induced by N-methyl-N'-nitro-N-nitroso-guanidine in rats on a low calcium and fat diet. Cancer Res 1990;50:1764-1767.
358. Preston-Martin S, Pike MC, Ross RK, Jones PA, Henderson BE. Increased cell division as a cause of human cancer. Cancer Res 1990;50:7415-7421.
359. Ames BN, Gold LS, Willett WC. The causes and prevention of cancer. PNAS USA 1995;92:5258-5265.
360. Lipkin M, Blattner WE, Fraumeni JF Jr, Lynch HT, Deschner E, Winawer S. Tritiated thymidine (øp, øh) labeling distribution as a marker for hereditary predisposition to colon cancer. Cancer Res 1983;43:1899-1904.
361. Ponz de Leon M, Roncucci L, Di Donato P, Tassi L, Smerieri O, Grazia M, Malagoli AG, De Maria D, Antonioli A, Chahin N, Perini M, Rigo G, Barberini G, Manenti A, Biasco G, Barbara L. Pattern of epithelial cell proliferation in colorectal mucosa of normal subjects and of patients with adenomatous polyps or cancer of the large bowel. Cancer Res 1988;48:4121-4126.
362. Scalmati A, Lipkin M. Intermediate biomarkers of increased risk for colorectal cancer: Comparison of different methods of analysis and modifications by chemopreventive interventions. J Cell Biochem Suppl 1992;16G:65-71.
363. Lipkin M, Newmark H. Effect of added dietary calcium on colonic epithelial-cell proliferation in subjects at high risk for familial colonic cancer. N Engl J Med 1985;313:1381-1384.
364. Palmieri GMA. Dietary calcium and colonic cancer (letter). N Engl J Med 1986;314:1388.
365. Anti M, Marra G, Armelao F, Percesepe A, Ficarelli R, Ricciuto GM, Valenti A, Rapaccini GL, de Vitis I, D'Agostino G, Brighi S, Vecchio FM. Rectal epithelial cell proliferation patterns as predictors of adenomatous colorectal polyp recurrence. Gut 1993;34:525-530.
366. Bleiberg H, Buyse M, Galand P. Cell kinetic indicators of premalignant stages of colorectal cancer. Cancer 1985;56:124-129.
367. Lipkin M, Blattner WA, Gardner EJ, Burt RW, Lynch H, Deschner E, Winawer S, Fraumeni JF Jr. Classification and risk assessment of individuals with familial polyposis, Gardner's syndrome and familial non-polyposis colon cancer from [3H]thymidine labeling patterns in colonic epithelial cells. Cancer Res 1984;44:4201-4207.
368. Lipkin M, Enker WE, Winawer SJ. Tritiated-thymidine labeling of rectal epithelial cells in "non-prep" biopsies of individuals at increased risk for colonic neoplasia. Cancer Lett 1987;37:153-161.
369. Lipkin M, Uehara K, Winawer S, Sanchez A, Bauer C, Phillips R, Lynch HT, Blattner WA, Fraumeni JF Jr. Seventh-Day Adventist vegetarians have quiescent proliferative activity in colonic mucosa. Cancer Lett 1985;26:139-144.
370. Paganelli GM, Biasco G, Santucci R, Brandi G, Lalli AA, Miglioli M, Barbara L. Rectal cell proliferation and colorectal cancer risk level in patients with nonfamilial adenomatous polyps of the large bowel. Cancer 1991;68:2451-2454.
371. Risio M, Lipkin M, Candelaresi G, Bertone A, Coverlizza S, Rossini FP. Correlations between rectal mucosa cell proliferation and the clinical and pathological features of nonfamilial neoplasia of the large intestine. Cancer Res 1991;51:1917-1921.
372. Rooney PS, Clarke PA, Gifford KA, Hardcastle JD, Armitage NC. Identification of high and low risk groups of colorectal cancer using rectal mucosal crypt cell production rate (CCPR). Br J Cancer 1993;68:172-175.
373. Scalmati A, Roncucci L, Ghidini G, Biasco G, Ponz de Leon M. Epithelial cell kinetics in the remaining colorectal mucosa after surgery for cancer of the large bowel. Cancer Res 1990;50:7937-7941.
374. Stadler J, Yeung KS, Furrer R, Marcon N, Himal HS, Bruce WR. Proliferative activity of rectal mucosa and soluble fecal bile acids in patients with normal colons and in patients with colonic polyps or cancer. Cancer Lett 1988;38:315-320.
375. Terpstra OT, van Blankenstein M, Dees J, Eilers GAM. Abnormal pattern of cell proliferation in the entire colonic mucosa of patients with colon adenoma or cancer. Gastroenterology 1987;92:704-708.
376. Welberg JW, de Vries EG, Hardonk MJ, Mulder NH, Harms G, Grond J, Zwart N, Koudstaal J, de Ley L, Kleibeuker JH. Proliferation rate of colonic mucosa in normal subjects and patients with colonic neoplasms: A refined immunohistochemical method. J Clin Pathol 1990;43:453-456.
377. Barsoum GH, Hendrickse C, Winslet MC, Youngs D, Donovan IA, Neoptolemos JP, Keighley MR. Reduction of mucosal crypt cell proliferation in patients with colorectal adenomatous polyps by dietary calcium supplementation. Br J Surg 1992;79:581-583.
378. Cats A, Kleibeuker JH, van der Meer R, Kuipers F, Sluiter WJ, Hardonk MJ, Oremus ET, Mulder NH, de Vries EG. Randomized, double-blinded, placebo-controlled intervention study with supplemental calcium in families with hereditary nonpolyposis colorectal cancer. J Natl Cancer Inst 1995;87:598-603.
379. Deschner EE, Lewis DM, Lipkin M. In vitro study of human rectal epithelial cells. 1. Atypical zone of H3 thymidine incorporation in mucosa of multiple polyposis. J Clin Invest 1963;42:1922-1928.
380. Riddell RH. Dysplasia and cancer in ulcerative colitis: A soluble problem? Scand J Gastroenterol 1984;19 (Suppl. 104):137-149.
381. Biasco G, Lipkin M, Minarini A, Higgins P, Miglioli M, Barbara L. Proliferative and antigenic properties of rectal cells in patients with chronic ulcerative colitis. Cancer Res 1984;44:5450-5454.
382. Bleiberg H, Mainguet P, Galand P, Chretien J, Dupont-Mairesse M. Cell renewal in the human rectum: In vitro autoradiographic study on active ulcerative colitis. Gastroenterology 1970;58:851-855.
383. Deschner EE, Winawer SJ, Katz S, Katzka I, Kahn E. Proliferation defects in ulcerative colitis patients. Cancer Invest 1983;1:41-47.
384. Gerdes H, Gillin JS, Zimbalist E, Urmacher C, Lipkin M, Winawer SJ. Expansion of the epithelial proliferative compartment and frequency of adenomatous polyps in the colon correlate with strength of family history of colorectal cancer. Cancer Res 1993;53:279-282.
385. Bradham C, Quian T, Streetz K, Trautwein C, Brenner DA, Lemasters JJ. The mitochondrial permeability transition is required for tumor necrosis factor ?-mediated apoptosis and cytochrome c release. Mol Cell Biol 1998;18:6353-6364.
386. Paganelli GM, Santucci R, Biasco G, Miglioli M, Barbara L. Effect of sex and age on rectal cell renewal in humans. Cancer Lett 1990;53:117-121.
387. Roncucci L, Ponz de Leon M, Scalmati A, Malgoli G, Pratissoli S, Perini M, Chalin NJ. The influence of age on colonic epithelial cell proliferation. Cancer 1988;62:2373-2377.
388. Wargovich MJ, Lointier PH. Calcium and vitamin D modulate mouse colon epithelial proliferation and growth characteristics of a human colon tumor cell line. Can J Physiol Pharmacol 1987;65:472-477.
389. Risio M, Coverlizza M, Ferrari A, Candelaresi G, Rossini F. Immunohistochemical study of epithelial cell proliferation in hyperplastic polyps, adenomas, and adenocarcinomas of the large bowel. Gastroenterology 1988;94:899-906.
390. Lipkin M, Newmark H. Effect of added dietary calcium on colonic epithelial-cell proliferation in subjects at high risk for familial colonic cancer. N Engl J Med 1985;313:1381-1384.
391. Anti M, Marra G, Armelao F, Bartoli GM, Ficarelli R, Percesepe A, de Vitis I, Maria G, Sofo L, Rapaccini GL, Gentiloni N, Piccioni E, Miggiano G. Effect of ?-3 fatty acids on rectal mucosal cell proliferation in subjects at risk for colon cancer. Gastroenterology 1992;103:883-891.
392. Biasco G, Zannoni U, Paganelli GM, Santucci R, Gionchetti P, Rivolta G, Miniero R, Pironi L, Calabrese C, Di Febo G, Miglioli M. Folic acid supplementation and cell kinetics of rectal mucosa in patients with ulcerative colitis. Cancer Epidemiol Biomarkers Prev 1997;6:469-471.
393. Cascinu S, Del Ferro E, Grianti C, Foglietti GP, Olivieri Q, Bartolucci M, Saba V, Lungarotti F, Catalano G. Hyperproliferative status of the epithelium in the remaining colorectal mucosa after surgery for cancer of the large bowel: Its implications in the prediction of adenomatous polyps recurrence. GI Cancer 1995;1:119-122.
394. Nakamura S, Kino I, Baba S. Nuclear DNA content of isolated crypts of background colonic mucosa from patients with familial adenomatous polyposis and sporadic colorectal cancer. Gut 1993;34:1240-1244.
395. Wargovich MJ. Phytic acid, a major calcium chelator from fiber-rich cereals stimulates colonic cellular proliferation (abstract). Gastroenterology 1986;90:1684.
396. Rafter JJ, Eng VWS, Furrer R, Bruce WR. Effects of calcium and pH on the mucosal damage produced by deoxycholic acid in the rat colon. Gut 1986;27:1320-1329.
397. Reddy BS, Watanabe K. Effect of cholesterol metabolism and promoting effect of lithocolic acid on colon carcinogenesis in germ-free and conventional F344 rats. Cancer Res 1979;39:1521-1524.
398. Glauert HP, Bennik MB. Influence of diet or intrarectal bile acid injections on colon epithelial cell proliferation in rats previously injected with 1,2-dimethylhydrazine. J Nutr 1983;113:475-482.
399. Lamprecht SA, Lipkin M. Chemoprevention of colon cancer by calcium, vitamin D and folate: Molecular mechanisms. Nat Rev Cancer 2003;3:601-614.
400. Mure K, Rossman TG. Reduction of spontaneous mutagenesis in mismatch repair-deficient and proficient cells by dietary antioxidants. Mutat Res 2001;480-481:85-95.
401. Kim JM, Araki S, Kim DJ, Park CB, Takasuka N, Baba-Toriyama H, Ota T, Nir Z, Khachik F, Shimidzu N, Tanaka Y, Osawa T, Uraji T, Murakoshi M, Nishino H, Tsuda H. Chemopreventive effects of carotenoids and curcumins on mouse colon carcinogenesis after 1,2-dimethylhydrazine initiation. Carcinogenesis 1998;19:81-85.
402. Sengupta A, Ghosh S, Das S. Tomato and garlic can modulate azoxymethane-induced colon carcinogenesis in rats. Eur J Cancer Prev 2003;12:195-200.
403. Narisawa T, Fukaura Y, Hasebe M, Nomura S, Oshima S, Sakamoto H, Inakuma T, Ishiguro Y, Takayasu J, Nishino H. Prevention of N-methylnitrosourea-induced colon carcinogenesis in F344 rats by lycopene and tomato juice rich in lycopene. Jpn J Cancer Res 1998;89:1003-1008.
404. Narisawa T, Fukaura Y, Hasebe M, Ito M, Aizawa R, Murakoshi M, Uemura S, Khachik F, Nishino H. Inhibitory effects of natural carotenoids, alpha-carotene, beta-carotene, lycopene and lutein, on colonic aberrant crypt foci formation in rats. Cancer Lett 1996;107:137-142.
405. Hu J, Liu Y, Yu Y, Zhao T, Liu S, Wang Q. Diet and cancer of the colon and rectum: A case-control study in China. Int J Epidemiol 1991;20:362-367.
406. Francheschi S, Bidoli E, La Vecchia C, Talamini R, D'Avanzo B, Negri E. Tomatoes and risk of digestive-tract cancers. Int J Cancer 1994;59:181-184.
407. Francheschi S, Favero A, La Vecchia C, Negri E, Conti E, Montella M, Giacosa A, Nanni O, Decarli A. Food groups and risk of colorectal cancer in Italy. Int J Cancer 1997;72:56-61.
408. Modan B, Cuckle H, Lubin F. A note on the role of dietary retinol and carotene in human gastro-intestinal cancer. Int J Cancer. 1981;28:421-424.
409. Nair PP, Lohani A, Norkus EP, Feagins H, Bhagavan HN. Uptake and distribution of carotenoids, retinol, and tocopherols in human colonic epithelial cells in vivo. Cancer Epidemiol Biomarkers Prev 1996;5:913-916.
410. Malila N, Virtamo J, Virtanen M, Pietinen P, Albanes D, Teppo L. Dietary and serum ?-tocopherol, ?-carotene and retinol, and risk for colorectal cancer in male smokers. Eur J Clin Nutr 2002;56:615-621.
411. Tuyns AJ, Kaaks R, Haelterman. Colorectal cancer and the consumption of foods: A case control study in Belgium. Nutr Cancer 1988;11:189-204.
412. Tajima K, Tominaga S. Dietary habits and gastro-intestinal cancers: a comparative case-control study of stomach and large intestinal cancers in Nagoya, Japan. Jpn J Cancer Res 1985;76:705-716.
413. Enger SM, Longnecker MP, Chen MJ, Harper JM, Lee ER, Frankl HD, Haile RW. Dietary intake of specific carotenoids and vitamins A, C, and E, and prevalence of colorectal adenomas. Cancer Epidemiol Biomarkers Prev 1996;5:147-153.
414. La Vecchia C, Braga C, Negri E, Franceschi S, Russo A, Conti E, Falcini F, Giacosa A, Montella M, Decarli A. Intake of selected micronutrients and risk of colorectal cancer. Int J Cancer 1997;73:525-530.
415. Slattery ML, Benson J, Curtin K, Ma KN, Schaeffer D, Potter JD. Carotenoids and colon cancer. Am J Clin Nutr 2000;71:575-582.
416. Terry P, Jain M, Miller AB, Howe GR, Rohan TE. Dietary carotenoid intake and colorectal cancer risk. Nutr Cancer 2002;42:167-172.
417. Levi F, Pasche C, Lucchini F, La Vecchia C. Selected micronutrients and colorectal cancer. A case-control study from the canton of Vaud, Switzerland. Eur J Cancer 2000;36:2115-2119.
418. Lauren P. The two histological main types of gastric carcinoma: Diffuse and so-called intestinal type carcinoma. Acta Path Microbiol Scand 1965;64:31-49.
419. Correa P. A human model of gastric carcinogenesis. Cancer Res 1988;48:3554-3560.
420. Yuasa Y. Control of gut differentiation and intestinal-type gastric carcinogenesis. Nat Rev Cancer 2003;3:592-600.
421. Mirvish SS. The etiology of gastric cancer: intragastric nitrosamide formation and other theories. J Natl Cancer Inst 1983;71:629-647.
422. Forman D. Dietary exposure to N-nitroso compounds and the risk of human cancer. Cancer Surv 1987;6:719-739.
423. Atanasova-Goranova VK, Dimova PI, Pevicharova GT. Effect of food products on endogenous generation of N-nitrosamines in rats. Br J Nutr 1997;78:335-345.
424. Velmurugan B, Bhuvaneswari V, Burra UK, Nagini S. Prevention of N-methyl-N'-nitro-N-nitrosoguanidine and saturated sodium chloride-induced gastric carcinogenesis in Wistar rats by lycopene. Eur J Cancer Prev 2002;11:19-26.
425. Velmurugan B, Bhuvaneswari V, Nagini S. Antiperoxidative effects of lycopene during N-methyl-N'-nitro-N-nitrosoguanidine-induced gastric carcinogenesis. Fitoterapia 2002;73:604-611.
426. Boeing H, Jedrychowski W, Wahrendorf J, Popiela T, Tobiasz-Adamczyk B, Kulig A. Dietary risk factors in intestinal and diffuse types of stomach cancer: A multicenter case-control study in Poland. Cancer Causes Control 1991;2:227-233.
427. Haenszel W, Kurihara M, Segi M, Lee RK. Stomach cancer among Japanese in Hawaii. J Natl Cancer Inst 1972;49:969-988.
428. Correa P, Fontham E, Pickle LW, Chen V, Lin YP, Haenszel W. Dietary determinants of gastric cancer in south Louisiana inhabitants. J Natl Cancer Inst 1985;75:645-654.
429. Hansson LE, Nyren O, Bergstrom R, Wolk A, Lindgren A, Baron J, Adami HO. Diet and risk of gastric cancer. A population-based case-control study in Sweden. Int J Cancer 1993;55:181-189.
430. De Stefani E, Boffetta P, Brennan P, Deneo-Pellegrini H, Carzoglio JC, Ronco A, Mendilaharsu M. Dietary carotenoids and risk of gastric cancer: A case-control study in Uruguay. Eur J Cancer Prev 2000;9:329-334.
431. Botterweck AA, van den Brandt PA, Goldbohm RA. Vitamins, carotenoids, dietary fiber, and the risk of gastric carcinoma: Results from a prospective study after 6.3 years of follow-up. Cancer 2000;88:737-748.
432. Garcia-Closas R, Gonzalez CA, Agudo A, Riboli E. Intake of specific carotenoids and flavonoids and the risk of gastric cancer in Spain. Cancer Causes Control 1999;10:71-75.
433. Gonzalez CA, Sanz JM, Marcos G, Pita S, Brullet E, Saigi E, Badia A, Riboli E. Dietary factors and stomach cancer in Spain: A multi-centre case-control study. Int J Cancer 1991;49:513-519.
434. La Vecchia C, Negri E, Decarli A, D'Avanzo B, Franceschi S. A case-control study of diet and gastric cancer in northern Italy. Int J Cancer 1987;40:484-489.
435. Ramon JM, Serra L, Cerdo C, Oromi J. Dietary factors and gastric cancer risk. A case-control study in Spain. Cancer 1993;71:1731-1735.
436. Tuyns AJ, Kaaks R, Haelterman M, Riboli E. Diet and gastric cancer. A case-control study in Belgium. Int J Cancer 1992;51:1-6.
437. Nakhlis F, Morrow M. Ductal carcinoma in situ. Surg Clin North Am 2003;83:821-839.
438. Adamovich TL, Simmons RM. Ductal carcinoma in situ with microinvasion. Am J Surg 2003;186:112-116.
439. Graham S, Hellmann R, Marshall J, Freudenheim J, Vena J, Swanson M, Zielezny M, Nemoto T, Stubbe N, Raimondo T. Nutritional epidemiology of postmenopausal breast cancer in western New York. Am J Epidemiol 1991;134:552-566.
440. Willett W. The search for the causes of breast and colon cancer. Nature 1989;338:389-394.
441. Singletary SE. Rating the risk factors for breast cancer. Ann Surg 2003;237:474-482.
442. Welsh J, Wietzke JA, Zinser GM, Smyczek S, Romu S, Tribble E, Welsh JC, Byrne B, Narvaez CJ. Impact of the Vitamin D3 receptor on growth-regulatory pathways in mammary gland and breast cancer. J Steroid Biochem Mol Biol 2002;83:85-92.
443. Papa V, Gliozzo B, Clark GM, McGuire WL, Moore D, Fujita-Yamaguchi Y, Vigneri R, Goldfine ID, Pezzino V. Insulin-like growth factor-I receptors are overexpressed and predict a low risk in human breast cancer. Cancer Res 1993;53:3736-3740.
444. Hankinson SE, Willett WC, Colditz GA, Hunter DJ, Michaud DS, Deroo B, Rosner B, Speizer FE, Pollak M. Circulating concentrations of insulin-like growth factor I and risk of breast cancer. Lancet 1998;351:1393-1396.
445. Karas M, Amir H, Fishman D, Danilenko M, Segal S, Nahum A, Koifmann A, Giat Y, Levy J, Sharoni Y. Lycopene interferes with cell cycle progression and insulin-like growth factor I signaling in mammary cancer cells. Nutr Cancer 2000;36:101-111.
446. Nahum A, Hirsch K, Danilenko M, Watts CK, Prall OW, Levy J, Sharoni Y. Lycopene inhibition of cell cycle progression in breast and endometrial cancer cells is associated with reduction in cyclin D levels and retention of p27(Kip1) in the cyclin E-cdk2 complexes. Oncogene 2001;20:3428-3436.
447. Ben-Dor A, Nahum A, Danilenko M, Giat Y, Stahl W, Martin HD, Emmerich T, Noy N, Levy J, Sharoni Y. Effects of acyclo-retinoic acid and lycopene on activation of the retinoic acid receptor and proliferation of mammary cancer cells. Arch Biochem Biophys 2001;391:295-302.
448. Prakash P, Russell RM, Krinsky NI. In vitro inhibition of proliferation of estrogen-dependent and estrogen-independent human breast cancer cells treated with carotenoids or retinoids. J Nutr 2001;131:1574-1580.
449. Nagasawa H, Mitamura T, Sakamoto S, Yamamoto K. Effects of lycopene on spontaneous mammary tumour development in SHN virgin mice. Anticancer Res 1995;15:1173-1178.
450. Sharoni Y, Giron E, Rise M, Levy J. Effects of lycopene-enriched tomato oleoresin on 7,12-dimethyl-benz[a]anthracene-induced rat mammary tumors. Cancer Detect Prev 1997;21:118-123.
451. Cohen LA, Zhao Z, Pittman B, Khachik F. Effect of dietary lycopene on N-methylnitrosourea-induced mammary tumorigenesis. Nutr Cancer 1999;34:153-159.
452. Levi F, Pasche C, Lucchini F, La Vecchia C. Dietary intake of selected micronutrients and breast-cancer risk. Int J Cancer 2001;91:260-263.
453. Ronco A, de Stefani E, Boffetta P, Deneo-Pellegrini H, Mendilaharsu M, Leborgne F. Vegetables, fruits, and related nutrients and risk of breast cancer: A case-control study in Uruguay. Nutr Cancer 1999;35:111-119.
454. Zhang S, Tang G, Russell RM, Mayzel KA, Stampfer MJ, Willett WC, Hunter DJ. Measurement of retinoids and carotenoids in breast adipose tissue and a comparison of concentrations in breast cancer cases and control subjects. Am J Clin Nutr 1997;66:626-632.
455. Smith-Warner SA, Spiegelman D, Yaun SS, Adami HO, Beeson WL, van den Brandt PA, Folsom AR, Fraser GE, Freudenheim JL, Goldbohm RA, Graham S, Miller AB, Potter JD, Rohan TE, Speizer FE, Toniolo P, Willett WC, Wolk A, Zeleniuch-Jacquotte A, Hunter DJ. Intake of fruits and vegetables and risk of breast cancer: A pooled analysis of cohort studies. JAMA 2001;285:769-776.
456. Levi F, La Vecchia C, Gulie C, Negri E. Dietary factors and breast cancer risk in Vaud, Switzerland. Nutr Cancer 1993;19:327-335.
457. Ewertz M, Gill C. Dietary factors and breast-cancer risk in Denmark. Int J Cancer 1990;46:779-784.
458. Jarvinen R, Knekt P, Seppanen R, Teppo L. Diet and breast cancer risk in a cohort of Finnish women. Cancer Lett 1997;11:251-253.
459. Freudenheim JL, Marshall JR, Vena JE, Laughlin R, Brasure JR, Swanson MK, Nemoto T, Graham S. Premenopausal breast cancer risk and intake of vegetables, fruits, and related nutrients. J Natl Cancer Inst 1996;88:340-348.
460. La Vecchia C, Ferraroni M, Negri E, Franceschi S. Role of various carotenoids in the risk of breast cancer. Int J Cancer 1998;75:482-483.
461. Terry P, Jain M, Miller AB, Howe GR, Rohan TE. Dietary carotenoids and risk of breast cancer. Am J Clin Nutr 2002;76:883-888.
462. World Cancer Research Fund/American Institute for Cancer Research. Food, Nutrition and the Prevention of Cancer: A Global Perspective. American Institute for Cancer Research, Washington, DC, 1997, p. 303.
463. Cuzick J, Terry G, Ho L, Hollingworth T, Anderson M. Human papillomavirus type 16 DNA in cervical cancers as a predictor of high-grade cervical cancer. Lancet 1992;339:959-960.
464. Bosch FX, Munoz N, de Sanjose S, Guerrerro E, Ghaffari AM, Kaldor J, Castellsague X, Shah KV, Gaffari AM. Importance of human papillomavirus endemicity in the incidence of cervical cancer: An extension of the hypothesis on sexual behaviour. Cancer Epidemiol Biomarkers Prev 1994;3:375-379.
465. Pillai MR, Halabi S, McKalip A, Jayaprakash PG, Rajalekshmi TN, Nair MK, Herman B. The presence of human papillomavirus-16/-18 ET AL6, p53, and Bcl-2 protein in cervicovaginal smears from patients with invasive cervical cancer. Cancer Epidemiol Biomarkers Prev 1996;5:329-335.
466. de Vet HC, Knipschild PG, Grol MEC, Schouten HJA, Sturmans F. The role of beta-carotene and other dietary factors in the etiology of cervical dysplasia: results of a case-control study. Int J Epidemiol 1991;20:603-610.
467. Marshall JR, Graham S, Byers T, Swanson M, Brasure J. Diet and smoking in the epidemiology of cancer of the cervix. J Natl Cancer Inst 1983;70:847-851.
468. World Cancer Research Fund/American Institute for Cancer Research. Food, Nutrition and the Prevention of Cancer: A Global Perspective. American Institute for Cancer Research, Washington, DC, 1997, p. 296.
469. Duggan BD, Felix JC, Muderspach LI, Tourgeman D, Zheng J, Shibata D. Microsatellite instability in sporadic endometrial carcinoma. J Natl Cancer Inst 1994;86:1216-1221.
470. Jain MG, Rohan TE, Howe GR, Miller AB. A cohort study of nutritional factors and endometrial cancer. Eur J Epidemiol 2000;16:899-905.
471. McCann SE, Freudenheim JL, Marshall JR, Brasure JR, Swanson MK, Graham S. Diet in the epidemiology of endometrial cancer in western New York (United States). Cancer Causes Control 2001;11:965-974.
472. World Cancer Research Fund/American Institute for Cancer Research. Food, Nutrition and the Prevention of Cancer: A Global Perspective. American Institute for Cancer Research, Washington, DC, 1997, p. 290.
473. Cramer DW, Kuper H, Harlow BL, Titus-Ernstoff L. Carotenoids, antioxidants and ovarian cancer risk in pre- and postmenopausal women. Int J Cancer 2001;94:128-134.
474. World Cancer Research Fund/American Institute for Cancer Research. Food, Nutrition and the Prevention of Cancer: A Global Perspective. American Institute for Cancer Research, Washington, DC, 1997, p. 178.
475. Bueno de Mesquita HB, Maisonneuve P, Runia S, Moerman CJ. Intake of foods and nutrients and cancer of the exocrine pancreas: A population-based case-control study in the Netherlands. Int J Cancer 1991;48:540-549.
476. Baghurst PA, McMichael AJ, Slavotinek AH, Baghurst KI, Boyle P, Walker AM. A case-control study of diet and cancer of the pancreas. Am J Epidemiol 1991;134:167-179.
477. Mills PK, Beeson WL, Abbey DE, Fraser GE, Phillips RL. Dietary habits and past medical history as related to fatal pancreas cancer risk among Adventists. Cancer 1988;61:2578-2585.
478. McClain MR, Bausch J. Summary of safety studies conducted with synthetic lycopene. Regul Toxicol Pharmacol 2003;37:274-285.
479. Product Data. Lycopene 5% TG. Product Data Sheet 1080, July 13, 2001. D.S.M. N.V., Heerlen, The Netherlands.
480. Elinder LS, Hadell K, Johansson J, Molgaard J, Holme I, Olsson AG, Walldius G. Probucol treatment decreases serum concentrations of diet-derived antioxidants. Arterioscler Thromb Vascr Biol 1995;15:1057-1063.